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CHAPTER I  
 
FLIPPASES AND VESICLE-MEDIATED PROTEIN TRANSPORT 
 
The P-type ATPase Superfamily 
P-type ATPases are a large, evolutionary conserved family of membrane proteins 
that are involved in active transport of charged substrates, such as cations, across 
biological membranes (Moller et al., 1996; Kuhlbrandt, 2004; Paulusma and Oude 
Elferink, 2005). Members of the P-type ATPase superfamily are widely expressed in 
virtually all organisms. Based on sequence homology, this large family can be divided 
into five subfamilies referred to as types I –V (Axelsen and Palmgren, 1998; Palmgren 
and Axelsen, 1998; Kuhlbrandt, 2004). Each subfamily may be further divided into two 
or more subtypes, each unique for their transport substrates. Well studied examples of 
P-type ATPases are provided in Table 1-1 and organized by classification. Type IV 
ATPases, or P4-ATPases, are involved in lipid transport and will be the main focus of this 
thesis. These “lipid flippases” are thought to translocate phospholipids from the 
extracellular or luminal leaflet of the membrane to the cytosolic leaflet. 
The P-type designation derives from the formation of a covalent 
aspartyl-phosphate catalytic intermediate, which is intimately linked with the 
translocation process. The general mechanism by which substrates are pumped by P-type 
 1
ATPases is described as the Post-Albers cycle. In this model, two distinct conformations 
of the enzyme with different affinity for ions and nucleotides are called the E1 and E2 
states (Figure 1-1). In the E1 state, the ATPase contains high-affinity ion 1-binding sites 
that are exposed to the cytosol. Following the binding of ion 1 and Mg2+-ATP, the 
enzyme is phosphorylated at the invariant aspartic acid residue to form a phosphorylated 
E1-P state. The ATPase then undergoes a change in conformation to the E2-P state, which 
has reduced affinity to ion 1 and releases it to the lumenal or the extracellular side of the 
membrane. Ion 2 binds from the lumenal or the extracellular side, and subsequently 
escapes to the cytosol on dephosphorylation of the aspartic acid. The ATPase is then 
ready to start another cycle. 
 
 
 
 
Table 1-1: Members of the P-type ATPase Superfamily 
 
SUBFAMILY SUBTYPE EXAMPLES 
A E.coli Kdp K+-ATPase Type I 
B Heavy metal pumps, Cu2+-ATPase 
A Sarcoplasmic-reticulum Ca2+-ATPase 
B Plasma membrane Ca2+-ATPase 
C Na+/K+-ATPase, Gastric H+/K+-ATPase 
Type II 
D Na+-ATPase 
A H+-ATPase Type III 
B Bacterial Mg2+-ATPase 
Type IV / Phospholipid translocases 
Type V / Yeast Cod1p/Spf1p (substrate unknown)
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Figure 1-1: Structure and catalytic cycle of P-type ATPase 
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Figure 1-1: Structure and catalytic cycle of P-type ATPase. 
(A) Crystal structure of the SR-Ca2+–ATPase in the E1 state (From: Toyoshima et al., 
2000; Kuhlbrandt, 2004).  
(B) Crystal structure of the SR-Ca2+-ATPase in the thaipsigargin-inhibited E2 state. 
(From Toyoshima and Nomura, 2002; Kuhlbrandt, 2004) 
(C) Schematic diagram of the catalytic cycle of P-type ATPases. In the E1 state, ion 1 (X+) 
comes from the cytosol, and binds to its high-affinity binding site in the membrane (M) 
domain. The crucial Asp residue in the phosphorylation (P)-domain is then 
phosphorylated by Mg2+-ATP, which is delivered by the nucleotide-binding (N)-domain, 
resulting in the formation of the E1-P state. In the E1-P to E2-P transition, the P domain 
reorientates its position, while the actuator (A)-domain rotates to bring its TGE loop into 
close contact with the phosphorylation site. This movement of P domain and A-domain 
also induces the movement of the M-domain, which shuts off the cytosolic ion-access 
channel and disrupts the high-affinity X+ binding site. X+ is then released to the 
extracellular or lumenal side. Ion 2 (Y+) binds from the lumenal or the extracellular side, 
and subsequently escapes to the cytosol on dephosphorylation of the Asp residue. The 
ATPase is then ready to start another cycle. (From Kuhlbrandt, 2004) 
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Structural studies of P-type ATPases mainly focus on four members of this family: 
the Na+/K+-ATPase, sarcoplasmic reticulum-Ca2+-ATPase (SR-Ca2+-ATPase), gastric 
H+/K+-ATPase and plasma membrane H+-ATPase. So far, crystal structures with atomic 
resolution are available only for the SR-Ca2+-ATPase (Toyoshima et al., 2000; Toyoshima 
and Nomura, 2002; Toyoshima and Inesi, 2004). Remarkably, the SR-Ca2+-ATPase has 
been crystallized in four different conformations, providing a dramatic view of the 
conformational changes associated with the catalytic cycle. P-type ATPases share a 
common topology and typically have 10 transmembrane helices with both amino- and 
carboxyl- termini protruding into the cytosol. According to the model derived from 
structural studies (Figure1-1), four principal domains are defined in the SR-Ca2+-ATPase. 
The phosphorylation (P) domain lies in the large intracellular loop between 
membrane-spanning helices M4 and M5. Since this domain contains the P-type signature 
aspartic acid which gets phosphorylated during the catalytic cycle, it is the catalytic core 
of the P-type ATPases. The nucleotide-binding (N) domain is a large insert in the 
P-domain. A conserved sequence including a lysine residue is characteristic of the 
nucleotide-binding site. The actuator (A) domain is formed by the loop between helices 
M2 and M3 and the N-terminal tail leading into M1. The A-domain rotates to make close 
contact with the P-domain during the catalytic cycle, causing substantial conformational 
changes in the transmembrane segments. The membrane (M) domain comprises the 10 
transmembrane helices and the short connecting loops on the extracellular or the lumenal 
side of the membrane. For the SR-Ca2+-ATPase, the ion-binding sites are surrounded by 
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transmembrane helices M4, M5, M6 and M8, which provide polar and acidic side chains 
to coordinate the two ions. During the ion-pumping process, the M-domain rearranges 
dramatically, leading to a drastic affinity change for the ion-binding sites, and the opening 
and closing of pathways leading to the cytosol or extracytosolic compartments. 
P4-type ATPases are different from other subfamilies in that they are thought to 
translocate phospholipids rather than cations across the membrane bilayer. Because of the 
substrate specificity of the P4-ATPases, their activity appears to establish an asymmetric 
distribution of phospholipid species across the bilayer. Recently, studies in yeast have 
demonstrated a surprising requirement for these ATPases in vesicle-mediated protein 
trafficking. The scope of this chapter is to highlight the role of P4-ATPases in membrane 
asymmetry and protein trafficking, and to relate their cellular functions to their proposed 
phospholipid translocase activity. 
 
P4-ATPases and Membrane Asymmetry 
 
Membrane Asymmetry and Its Regulation 
Biological membranes are lipid bilayers that are mainly formed from 
glycerophospholipids, sphingolipids and sterols along with the embedded integral 
membrane proteins. Some lipids such as diacylglycerol, cholesterol or 
phosphatidylglycerol can move rapidly from one leaflet to the other in seconds or 
minutes in artificial membranes. This transbilayer movement is called lipid “flip-flop”. 
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On the contrary, phospholipids that bear polar head groups, such as phosphatidylcholine 
(PC), phosphatidylserine (PS) and phosphatidylethanolamine (PE), take hours to days to 
equilibrate between the two leaflets of artificial bilayers (Kornberg and McConnell, 1971) 
(reviewed in (Zachowski, 1993)). Consequently, these slow-flipping lipid species can be 
non-randomly distributed between the two leaflets of the membrane bilayer. For example, 
the plasma membrane of most eukaryotic cells exhibits an asymmetric lipid arrangement 
with sphingomyelin (SM) and PC located preferentially on the extracellular leaflet, while 
PS, PE and phosphatidylinositol (PI) are restricted to the cytosolic leaflet (Zachowski, 
1993; Daleke, 2003).  
Maintenance of phospholipid asymmetry is an important process associated with 
many physiological and pathological events. For example, exposure of PS and/or PE to 
the extracellular leaflet of the plasma membrane is important for platelet activation and 
clearance of apoptotic cells by phagocytes (Williamson and Schlegel, 2002; 
Balasubramanian and Schroit, 2003). Furthermore, lipid asymmetry between the bilayer 
leaflets can affect membrane morphology as suggested by the bilayer-couple hypothesis 
of Sheetz and Singer (Sheetz and Singer, 1974; Sheetz et al., 1976). Based on the effect 
of various membrane intercalating compounds on the shape of red blood cells, this 
hypothesis postulates that the two leaflets are physically coupled together and an increase 
in the surface area of one leaflet relative to the other would spontaneously increase 
membrane curvature (Sheetz and Singer, 1974; Sheetz et al., 1976). Amphipathic drugs 
that preferentially incorporated in to the PC and sphingomyelin enriched outer leaflet 
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bend the membrane outward and crenate the erythrocytes. In contrast, compounds that 
intercalate into the aminophospholipid-rich cytosolic leaflet cause an inward bending to 
generate stomatocytes. 
Lipid asymmetry is tightly regulated by the synergistic action of three classes of 
proteins that function to translocate lipids across the membrane: flippases, floppases and 
scramblases (Daleke, 2003). Scramblases dissipate lipid asymmetry by mediating 
energy-independent, bi-directional lipid movement with little specificity. In red blood 
cells and platelets, scramblase activity is stimulated by an influx of calcium, leading to 
PS exposure and stimulation of blood clotting. The ER appears to have a similar, 
although calcium-independent activity that allows uniform growth of both leaflets during 
membrane biogenesis. In contrast to scramblases, the activities of both flippases and 
floppases are energy-dependent and are required to establish and maintain lipid 
asymmetry. Flippases catalyze the inward movement of phospholipids from either the 
extracellular or lumenal leaflet to the cytosolic leaflet, whereas floppases mediate a 
reverse outward reaction. The protein responsible for scramblase activity is unknown, 
while flippase and floppase activities are apparently catalyzed by P4-ATPases and ATP 
binding cassette (ABC) transporters, respectively.  
 
The Aminophospholipid Translocase (APLT) 
In 1984, Seigneuret and Devaux first discovered a PS and PE-specific 
ATP-dependent flippase, which they named aminophospholipid translocase (APLT), by 
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measuring the translocation of spin-labeled phospholipid derivatives across the plasma 
membrane of erythrocytes (Seigneuret and Devaux, 1984). This and later studies also 
demonstrated that the addition of different exogenous phospholipids have unique impacts 
on the shape of erythrocytes, depending on whether or not the phospholipid is a substrate 
for the APLT (Seigneuret and Devaux, 1984; Daleke and Huestis, 1985; Daleke and 
Huestis, 1989). On addition of spin-labeled PC, PS or PE, erythrocytes immediately 
become crenated as the lipid intercalates into the outer leaflet. With further incubation, 
erythrocytes with the PC analogue remain crenated because this lipid is not a substrate of 
the APLT. In contrast, erythrocytes with PS or PE analogues display shape changes 
associated with translocation of the lipid to the inner leaflet, which bends the plasma 
membrane inward, transforming the cells to a discoid shape and eventually an uniconcave 
disc-like shape (Figure 1-2) (Seigneuret and Devaux, 1984). These results are consistent 
with the existence of a protein in erythrocytes that specifically translocates 
aminophospholipids to the inner leaflet of the plasma membrane.  
The biochemical properties of the APLT have been well characterized. Transport 
activity is dependent on ATP and Mg2+, but inhibited by N-ethylmaleimide, vanadate and 
Ca2+ (Seigneuret and Devaux, 1984; Daleke and Huestis, 1985; Bitbol et al., 1987; 
Daleke and Huestis, 1989). The stoichiometry of translocation is approximately one lipid 
per ATP consumed (Beleznay et al., 1993). The flippase prefers PS over other lipids and 
the selectivity for PS is determined by multiple elements of lipid structure. The amino 
group is essential and monomethylation of PS is tolerable. The carboxyl group is not 
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absolutely required, since PE is also transported, although at a much lower rate. While the 
stereochemistry of serine headgroup is unimportant for recognition, the stereochemistry 
of the glycerol backbone is absolutely required: the sn-2,3-glycerol analog of the 
naturally-occurring sn-1,2-glycerol-lipid can not stimulate ATPase activity, nor can it be 
translated across the plasma membrane of erythrocytes (Daleke, 1995; Daleke, 2003). 
The transport of PS or PE seems to be independent of the length and composition of acyl 
chains. Thus, spin and fluorescent labeled lipids, attached to a short (e.g. C6) acyl chain 
in the sn-2 position, are widely used to study the APLT activity (Seigneuret and Devaux, 
1984; Daleke and Huestis, 1985; Colleau et al., 1991; Devaux et al., 2002). 
In 1989, an APLT activity was identified in the membrane of chromaffin granules 
(Zachowski et al., 1989). Since the biochemical properties of this APLT are similar to 
ATPase II purified from chromaffin granules (Moriyama and Nelson, 1988), it was 
suggested that ATPase II was the indeed the APLT. In 1996, the gene that encodes ATPase 
II was cloned and found to share a high degree of sequence similarity to Drs2p from 
budding yeast (Tang et al., 1996). The presence of multiple P-type ATPase motifs 
indicated that ATPase II and Drs2p belonged to the P-type ATPase family. In fact, they 
are the founding members of the P4-ATPases, which are widely expressed in various 
eukaryotes including fungi, protozoa, insects, plants and animals (Table 1-2), but do not 
appear to be present in eubacteria and archaebacteria.   
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Figure 1-2: Scanning electron micrograghs of erythrocytes incubated for 3 min (A) or 6.5 
hr (B) at 5°C after labeling with exogenous PS (1-palmitoyl-2-(4-doxylpentanoyl) 
phosphatidylserine). (From Seigneuret and Devaux, 1984) 
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Table 1-2: P4-ATPases in Different Organisms 
SPECIES SUBUNIT # OF 
MEMBERS
REFERENCES REPRESENTATIVE 
GENES 
α 5 (Catty et al., 1997) NEO1 
DRS2/SWA3 
DNF1 
DNF2 
DNF3 
Saccharomyces 
cerevisiae 
β 3  CDC50/SWA4 
LEM3/ROS3 
CRF1 
Saccharomyces 
Pombe 
α 5 (Okorokova-Facanha 
et al., 2003) 
 
Magnaporthe 
Grisea 
α 4  MgPDE1 
MgAPT2 
α /  LdMT Leishmania 
donovani β /  LdRos3 
Caenorhabditis 
elegans 
α 6 (Halleck et al., 1998; 
Okamura et al., 2003)
 
Drosophila 
melanogaster 
α 6 (Okamura et al., 
2003) 
 
α 12 (Axelsen and 
Palmgren, 2001; 
Baxter et al., 2003) 
ALA1 Arabidopsis 
thaliana 
β 5   
Oryza sativa α 10 (Baxter et al., 2003)  
α 14 (Halleck et al., 1998; 
Halleck et al., 1999; 
Williamson and 
Schlegel, 2002; 
Paulusma and Oude 
Elferink, 2005) 
ATP8A1(ATPase II) 
ATP8A2 
ATP8B1/FIC1 
ATP8B3 
ATP10A/ATP10C 
ATP10D 
ATP11A 
ATP11C 
mammalian 
β 3 (Katoh and Katoh, 
2004; Osada et al., 
2006) 
TMEM30A 
TMEM30B 
TMEM30C 
 12
P4-ATPases Are Potential Phospholipid Translocases 
1. Mammalian P4-ATPases 
Database searches and phylogenetic analysis identified 14 P4-ATPases in 
mammals (Table 1-2). An expression profile of a panel of P4-ATPases revealed that these 
proteins are expressed in a development- and tissue-specific manner, suggesting that they 
are not simply redundant. In addition, they may also differ in subcellular localization and 
substrate specificity (Halleck et al., 1998; Halleck et al., 1999; Soupene and Kuypers, 
2006; Sobocki et al., 2007). Our knowledge of the biochemical properties of P4-ATPases 
is primarily based on characterization of ATPase II (ATP8A1), which strongly resembles 
the previously characterized APLT in the plasma membrane of erythrocytes (Moriyama 
and Nelson, 1988; Paterson et al., 2006). Xie’s group was the first to express and purify 
recombinant Atp8a1 from insect cells (Ding et al., 2000). In their studies, the 
phosphoenzyme intermediate could form in the absence of PS, but required PS for 
dephosphorylation, consistent with PS being a substrate pumped towards the cytosol 
during the E2->E1 transition. Recently, Daleke and colleagues monitored the activity of 
recombinant Atp8a1 in detergent micelles containing various lipids (Paterson et al., 2006). 
Their data strongly correlate the potential substrates that stimulate Atp8a1 activity with 
substrates transported across the erythrocyte plasma membrane by the APLT. However, 
experiments in which purified enzyme is reconstituted are still needed to directly 
demonstrate the transport activity of Atp8a1. In addition, the identity of the erythrocyte 
APLT remains unknown. So whether the APLT is Atp8a1, one of the 13 other P4-ATPase 
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or a different ATPase altogether is not clear.  
Up to now, only one P4-ATPase gene, FIC1 (ATP8B1), has been unambiguously 
linked to human disease (Paulusma and Oude Elferink, 2005). Mutations in FIC1 cause 
inherited progressive familial intrahepatic cholestasis type 1 (PFIC1) and benign 
recurrent intrahepatic cholestasis (BRIC) (Bull et al., 1998; Bull et al., 1999; Tygstrup et 
al., 1999; Klomp et al., 2000; Eppens et al., 2001; Ujhazy et al., 2001; Klomp et al., 
2004). PFIC1/BRIC patients are characterized by impaired bile salt secretion, high levels 
of serum bile salts and bilirubin, but normal levels of serum cholesterol and 
γ-glutamyltranspeptidase, an ectoenzyme whose serum activity is high in most cholestasis 
disorders. Obviously, dysfunction of Atp8b1 abrogates bile salt homeostasis and bile 
formation, but the molecular mechanism underlying the cholestatic phenotype is still not 
clear. Atp8b1 localizes to the apical membrane of epithelial cells in many tissues, 
including hepatocytes and bile duct epithelial cells. Expression of Atp8b1 in a mutant 
CHO-K1 cell line, which is defective in the non-endocytic uptake of NBD-PS, increases 
translocation of NBD-PS across the plasma membrane (Ujhazy et al., 2001). These data 
are consistent with a proposed role for Atp8b1 as an APTL, but do not rule out an indirect 
impact of Atp8b1 on NBD-PS uptake. For example, Atp8b1 may affect expression or 
trafficking of other proteins which are directly responsible for the APTL activity. 
Recently, Oude Elferink’s group observed that after intravenous infusion of a 
hydrophobic bile salt, Atp8b1 deficient mice displayed enhanced levels of PS, cholesterol 
and ectoenzymes in the bile (Paulusma et al., 2006). Moreover, disruption of Atp8b1 
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abrogates the transport of hydrophobic bile salts into bile in isolated mouse livers. Based 
on these observations, this group proposes that loss of membrane asymmetry caused by 
Atp8b1 deficiency renders the canalicular membrane more sensitive to extraction of PS 
and cholesterol by bile salts, which in turn perturbs ABCB11 activity, the major bile salt 
export pump, and causes cholestasis.  
Besides FIC1, a few other diseases have been tentatively linked to P4-ATPase loci. 
The ATP8A2 locus is frequently deleted in tumorigenic malignancies (Sun et al., 1999). 
X-linked hypoparathyroidism maps to a chromosomal region, Xq27, containing the 
3’UTR of ATP11C (Andrew Nesbit et al., 2004). Moreover, a role of P4-ATPases in drug 
resistance was suggested by a recent report, showing that elevated levels of ATP11A 
protect the lymphoblastic leukemia cells against several small molecule signal 
transduction inhibitors (Zhang et al., 2005).  
P4-ATPases have been implicated in several different physiological processes in 
the mouse system. Heterozygous mice with a maternally-inherited chromosomal deletion 
impinging on ATP10A are predisposed to develop obesity and type 2 diabetes when fed a 
high-fat diet (Dhar et al., 2000; Dhar et al., 2002; Dhar et al., 2004a; Dhar et al., 2004b; 
Dhar et al., 2006). A similar, albeit less severe phenotype is exhibited by the inbred 
mouse strain C57BL/6J, which is linked to a premature stop codon in the ATP10D gene 
(Flamant et al., 2003). Thus, both ATP10A and ATP10D seem to be involved in the 
regulation of lipid metabolism. The mouse ortholog of ATP8B3 is exclusively expressed 
in the acrosomal region of spermatozoa. Loss of ATP8B3 compromises the ability of the 
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spermatozoa to bind and penetrate the zona pellucida and reduces the acrosome reaction 
(Wang et al., 2004). At this moment, how these P4-ATPases contribute to disease 
phenotypes is still poorly understood. However, studies in yeast have shed light on 
cellular and molecular functions of P4-ATPases, which may illuminate physiological 
processes perturbed by the diseases described above.  
2. Yeast P4-ATPases 
Five members of the P4-ATPase family are expressed in the yeast S. cerevisiae, 
including Neo1p, Drs2p, Dnf1p, Dnf2p, and Dnf3p. While deletion of NEO1 alone is 
lethal, DRS2, DNF1, DNF2 and DNF3 are individually nonessential genes. However, 
deletion of all four of these genes is lethal and so they constitute an essential group (Hua 
et al., 2002). The fact that any one of these four proteins can support cell viability implies 
that they share a common biochemical function. The drs2Δ strain grows as well as 
wild-type at 30°C, but fails to grow at 23°C or below. DNF1 and DNF2 are the closest 
related genes in this family, sharing 69% sequence identity and 83% similarity. In some 
strain backgrounds, dnf1Δdnf2Δ also causes a cold-sensitive growth defect (Pomorski et 
al., 2003). Different localization patterns are observed for individual yeast P4-ATPase 
members. While Drs2p and Dnf3p primarily reside in the trans-Golgi network (TGN), 
Dnf1p and Dnf2p localize to the plasma membrane and internal compartments, 
concentrating at the sites of polarized growth (i.e. emerging bud sites, small buds and 
mother-daughter neck of dividing cells) (Hua et al., 2002; Pomorski et al., 2003). Neo1p 
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appears to populate both endosomal membranes and the Golgi. All five P4-ATPases 
members have been implicated in protein trafficking, but act at different pathways (See 
below; Figure 1-3). As we will discuss later, the functional redundancy between these 
family members and roles they play in protein transport make it difficult to define the 
flippase activity of individual proteins by analyzing yeast strains carrying knockouts of 
P4 ATPase genes. 
As in mammalian cells, the plasma membrane of yeast is asymmetric with PS and 
PE restricted to the inner leaflet. However, unlike most mammalian cells, yeast can 
efficiently translocate NBD-PC cross the plasma membrane along with NBD-PS and 
NBD-PE, suggesting a broader substrate specificity for yeast translocases (Kean et al., 
1993; Grant et al., 2001; Hanson and Nichols, 2001). How active NBD-PC translocation 
relates to plasma membrane asymmetry remains unknown, although it is possible that 
most of the PC is in the inner leaflet and the outer leaflet is primarily glycosphingolipid. 
Among the five yeast P4-ATPases, Dnf1p and Dnf2p are the only two present on 
the plasma membrane, so they are most likely to be responsible for the flippase activity at 
the plasma membrane. Loss of Dnf1p and Dnf2p abolishes the ATP-dependent, 
non-endocytic uptake of NBD-labeled PE, PC and, to a lesser extent PS (Pomorski et al., 
2003). The dnf1Δdnf2Δ double mutant also exposes elevated levels of endogenous PE 
and PS on the cell surface (Pomorski et al., 2003; Chen et al., 2006). Specifically, 
wild-type cells expose a small amount of PE on the extracellular leaflet, and only at sites 
of polarized growth. In contrast, cell surface PE is also observed at the enlarged bud 
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cortex of dnf1Δdnf2Δ cells, suggesting Dnf1p and Dnf2p are involved in retrieval of PE 
at the bud cortex (Iwamoto et al., 2004). Uptake of three PC analogues with different 
Bodipy fluorophores was also tested and compared with that of NBD-PC in strains 
harboring deletions in DNF1 and DNF2 (Elvington et al., 2005). Loss of DNF1 and 
DNF2 significantly reduces the translocation of NBD-PC and Bodipy FL-PC across the 
plasma membrane, but does not perturb translocation of Bodipy 581-PC and Bodipy 
530-PC. ATP depletion and culture density also have a different impact on uptake of 
Bodipy 581-PC and Bodipy 530-PC. These observations suggest that in yeast there are at 
least three different translocation pathways which are selective for structure of the 
fluorophore attached to the acyl chain of PC molecules. dnf1Δdnf2Δ was shown to also 
perturb the endocytic pathway, so the data obtained from this mutant can not determine 
whether Dnf1p and Dnf2p directly translocate phospholipids, or whether other proteins 
that are depleted from the plasma membrane by the trafficking defects are more directly 
responsible for the phospholipid translocation.  
Whether or not disruption of Drs2 significantly decreases NBD-PS translocation 
across the plasma membrane and perturbs PS asymmetry was controversial in initial 
studies (Tang et al., 1996; Siegmund et al., 1998; Marx et al., 1999; Gomes et al., 2000). 
Using a more sensitive probe and peptides that specifically target PS and PE on the outer 
leaflet, recent studies were able to show that PS and PE asymmetry on the plasma 
membrane is impaired in drs2Δ cells (Chen et al., 2006). Deletion of DRS2 from 
dnf1Δdnf2Δ cells exacerbates the PE and PS exposure on the cell surface (Pomorski et al., 
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2003; Chen et al., 2006). Since Drs2p primarily localize to the TGN, it does not seem to 
contribute directly to the flippase activity on the plasma membrane. Instead, its activity 
may affect plasma membrane asymmetry in a couple of indirect ways. First, loss of Drs2 
may perturb exocytic vesicle formation at the TGN and accumulate cell-surface targeted 
proteins, including Dnf1p, in internal membranes (Saito et al., 2004). Moreover, 
membrane asymmetry may be established at the TGN by Drs2p before the membrane 
flows to the plasma membrane by exocytosis. Although Drs2p primarily localizes to the 
TGN, it does travel to the plasma membrane occasionally (Saito et al., 2004; Liu et al., 
2007). It remains under dispute whether Drs2p is active or not when present on the 
plasma membrane (Marx et al., 1999; Saito et al., 2004).  
Recently, a translocase activity that flips NBD-PS, NBD-PE and NBD-PC to the 
cytosolic leaflet was detected on a specific class of post-Golgi secretory vesicles 
containing Drs2p (Alder-Baerens et al., 2006). While vesicles purified from cells lacking 
Dnf1p and Dnf2p retained these activities, vesicles from cells deficient for Drs2p display 
impaired flippase activity for NBD-PS and, to a lesser extent, NBD-PE. In addition, 
translocation of all three lipid analogues is abolished on vesicles from cells deleted for 
both Drs2 and Dnf3. These data suggest that Dnf3 preferentially translocates NBD-PE 
and NBD-PC. 
At first glance, all the defects observed in the null mutants support the proposed 
flippase activity for Drs2p family of proteins. However, caution should be taken in 
interpreting these data, because the P4-ATPase null mutants may indirectly perturb the 
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expression, localization or activity of other proteins that directly translocate the 
NBD-phospholipids. For example, drs2Δ was recently shown to perturb cholesterol 
uptake across the plasma membrane (Reiner et al., 2006). Rather than directly 
transporting cholesterol, drs2Δ disrupts trafficking of the Aus1p and Pdr11p ABC 
transporters that appear to be the steroid transporters. The TGN membrane contains an 
energy-dependent flippase activity, which translocates NBD-labeled PS and PE from the 
luminal to the cytosolic leaflet (Natarajan et al., 2004). TGN membranes from drs2Δ cells 
exhibited a substantial decrease in this flippase activity (Our unpublished data). However, 
it was impossible to conclude that Drs2p was directly responsible for this flippase activity, 
because deletion of DRS2 causes mislocalization of several TGN resident enzymes and 
the TGN membranes purified from wild-type and drs2Δ cells have different protein 
compositions (Natarajan et al., 2004). In addition, other mutants with disrupted protein 
trafficking pathways, such as clathrin and endocytosis null mutants, also exhibit a loss of 
membrane asymmetry that is comparable to drs2Δ or dnf1Δdnf2Δ cells (Chen et al., 
2006). More importantly, acute inactivation of drs2-ts or chc-ts, results in defects in 
protein transport but fails to induce a measurable loss of PS asymmetry. Thus, PS 
exposure in the drs2-ts or chc-ts cells seems to be a secondary consequence of a chronic 
disruption in protein and membrane trafficking to and from the plasma membrane,  
Ideally, to determine if Drs2p is directly responsible for a flippase activity, one 
would like to compare membrane samples that differ only in the presence or absence of 
Drs2p activity. To achieve this goal, we applied two strategies with an in vitro flippase 
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assay using purified TGN membranes (Natarajan et al., 2004). First, all Dnf proteins were 
deleted from the cell to eliminate possible contribution of these proteins to the TGN 
flippase activity. Second, to avoid the chronic defects associated with loss of Drs2p, cells 
harboring either WT or temperature-sensitive alleles of Drs2 were grown at permissive 
temperature. By inactivating Drs2p-ts after membrane isolation, we could compare the 
flippase activity in the same membranes before and after inactivation of this single 
protein. These data demonstrated that Drs2p was required for ATP-dependent 
translocation of NBD-PS across TGN membranes, whereas no active translocation of 
NBP-PE or NBD-PC was detected with the TGN membranes isolated from the DRS2 
dnf1,2,3Δ cells. So far, these studies provide the most convincing evidence that Drs2p is 
indeed an APLT. Drs2p also appears to weakly translocate NBD-PE, an activity that can 
be detected when the protein is overexpressed.  
3. The Cdc50-Lem3 Family 
In yeast, an evolutionarily conserved family of proteins was found to associate 
with P4-ATPases as a potential noncatalytic subunit. Cdc50p, Lem3p and Crf1p are 
glycosylated proteins with two putative transmembrane domains. Cdc50p was originally 
identified in a screen for cold-sensitive, cell-division-cycle mutants, although it is still not 
clear why disruption of CDC50 causes a cold-sensitive block in the cell cycle (Moir et al., 
1982). CDC50 was later found to be allelic to SWA4 (described in more detail below) 
(Chen et al., 2006), a gene recovered in a genetic screen that also identified DRS2 (Chen 
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et al., 1999). Similar to drs2Δ, cdc50Δ mutants are impaired in protein transport, cell 
polarity and PS asymmetry of the plasma membrane (Saito et al., 2004; Chen et al., 
2006). Cdc50p physically interacts with Drs2p and the formation of this complex is 
required for ER exit of both proteins (Saito et al., 2004; Chen et al., 2006). Thus, the 
defects shown in cdc50Δ cells may be caused by loss of Drs2p function. Like Drs2p, 
Cdc50p localizes to the TGN and early endosome system, and accumulates on the plasma 
membrane when endocytosis is blocked, suggesting that the Drs2p-Cdc50p complex is 
maintained in post-ER compartments (Saito et al., 2004).  
LEM3 (also known as ROS3) was independently discovered in two screens for 
mutants that are either sensitive to an antifungal peptide that specifically binds to PE 
exposed on the outer leaflet of the plasma membrane, or are defective in the uptake of a 
toxic PC analogue (Kato et al., 2002; Hanson et al., 2003). Lem3p associates with and 
chaperones ER exit of Dnf1p and Dnf2p (Saito et al., 2004; Furuta et al., 2007). Thus, 
lem3Δ cells exhibit a deficiency of both Dnf1p and Dnf2p at the plasma membrane and 
consequently are impaired in translocation of NBD-PE and NBD-PC, but not NBD-PS 
across the plasma membrane (Kato et al., 2002; Hanson et al., 2003). Recently, a lem3 
mutant was isolated that exhibits normal association with Dnf1p and Dnf2p, an apparent 
normal localization of Dnf1p and nearly normal uptake of NBD-PE and NBD-PC, but 
displays a synthetic growth defect with cdc50Δ (Noji et al., 2006). This result suggests 
that Lem3p may regulate Dnf1p or Dnf2p function in more ways than just chaperoning 
their ER exit, or that Lem3p has some functions totally independent of Dnf1p and Dnf2p. 
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Like Cdc50p and Lem3p, Crf1p is a potential noncatalytic subunit that associates with 
Dnf3p (Furuta et al., 2007). Members of Cdc50p family proteins have also been 
identified in mammalian cells, although their function has not yet been explored (Katoh 
and Katoh, 2004; Osada et al., 2006). Many interesting questions remain about the 
Cdc50-Lem3 family of proteins: Are they dedicated subunits with P4-ATPases, or do they 
chaperone other proteins as well? Is their only function to escort the P4-ATPases from the 
ER or are they playing an essential role in lipid translocation? Are they required for 
proper membrane insertion, folding or association with COP II for ER exit? More 
experiments need to be done to resolve these issues.  
4. P4-ATPases in Other Organisms 
The cold sensitive growth of yeast drs2 mutants prompted the investigation of 
P4-ATPases in Arabidopsis, to determine if they are involved in chilling tolerance of 
plants (Gomes et al., 2000). Among the 11 P4-ATPases in Arabidopsis, ALA1 is the 
closest relative to DRS2, and is able to complement the cold sensitivity of the drs2 yeast 
mutants. Downregulation of ALA1 in Arabidopsis greatly impairs cold tolerance of the 
plant. The actual mechanism by which P4-ATPases participate in cold tolerance is not 
known, but is likely to be related to membrane integrity or fluidity. 
Two P4-ATPases from the rice blast fungus Magnaporthe grisea, MgAPT2 and 
MgPDE1, are required for fungal pathogenicity. Whereas MgPde1 is required for 
appressoria formation, an outgrowth of the plasma membrane used to penetrate the plant 
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cuticle (Balhadere and Talbot, 2001), MgApt2 plays a role in exocytosis of 
virulence-associated proteins and plant tissue colonization (Gilbert et al., 2006).  
A P4-ATPase called LdMT from Leishmania donovani, a parasite that causes 
visceral leishmaniasis, is associated with drug resistance. Parasites defective in LdMT are 
resistant to miltefosine, an alkylphosphocholine drug used to treat leishmaniasis. In 
addition, overexpression of LdMT increases the uptake of miltefosine by the parasites 
(Perez-Victoria et al., 2003). In fact, it was demonstrated earlier that yeast lem3Δ mutants 
are resistant to miltefosine (Hanson et al., 2003). A functional homolog of LEM3/ROS3 
was recently discovered in Leishmania donovani, and given the name LdRos3 
(Perez-Victoria et al., 2006). 
 
Yeast P4-ATPases in Protein Transport 
 
The Proposed Role of Flippases in Vesicle Biogenesis 
It has long been proposed that flippases, whose primary function is to establish 
and maintain membrane asymmetry, may play a role in vesicle biogenesis. Translocation 
of phospholipids by flippases increases the surface area of the cytosolic leaflet and 
coincidently decreases that of the extracellular leaflet. As suggested by the bilayer couple 
hypothesis (Sheetz and Singer, 1974), this imbalance of phospholipid number would 
induce membrane curvature towards the cytosol and hence facilitate vesicle formation. In 
fact, induced bilayer asymmetry can trigger shape changes of spherical liposomes into 
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tubular and interconnected vesicular structures (Farge and Devaux, 1992). 
Sphingomyelinase treatment, which changes the composition of the plasma membrane 
outer leaflet, induces an ATP-independent budding of functional endocytic vesicles (Zha 
et al., 1998). Moreover, exogenous PS or PE, when incorporated in the outer leaflet of the 
plasma membrane and then pumped to the inner leaflet, significantly enhances 
endocytosis (Farge et al., 1999). Conversely, addition of lyso−α-PS or a cholesterol 
derivative, which cannot be translocated across the plasma membrane and remains in the 
outer layer, inhibits endocytosis. Although these data described above are in agreement 
with the role of flippases in vesicle budding, they all deal with artificial membranes or 
perturbed cell systems. As we will discuss later, the requirements for yeast P4-ATPases in 
protein trafficking provide the first line of evidence that cells use a bilayer-couple 
mechanism under normal physiological conditions to generate vesicles.  
The role of generating the tight membrane curvature required in vesicle formation 
has traditionally been assigned to vesicle coat proteins like clathrin. Structural studies 
have revealed an intrinsic curvature in clathrin triskelia (Smith et al., 1998; Musacchio et 
al., 1999) and clathrin can self-assemble into polyhedral baskets in the absence of lipids. 
In an in vitro system, clathrin-coated buds and even clathrin-coated vesicles can form on 
appropriate protein-free liposomes, with a minimal requirement for ARF, GTP, adaptor 
proteins and clathrin (Takei et al., 1998; Zhu et al., 1999). However, recent theoretical  
studies estimated that the rigidity of clathrin-adaptor protein complexes is of the same 
order of magnitude as the resistance of lipid membranes to bending (Nossal, 2001). Thus, 
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clathrin assembly is unlikely to provide sufficient energy to drive membrane curvature in 
vivo, and instead, it may serve to stabilize an already curved membrane and prevent the 
membrane from collapsing back into a planar form. In the “Brownian ratchet” model, 
membranes spontaneously fluctuate, resulting in transient membrane invaginations, 
which could be captured by the clathrin lattice to form vesicles (Shraiman, 1997). 
Consistent with this model, additional accessory proteins with the ability to deform the 
membrane have been identified that participate in CCV formation, including 
BAR-domain containing proteins, the epsins (Itoh and De Camilli, 2006; Ren et al., 2006) 
as well as flippases.  
 
Requirements for P4-ATPases in Vesicle-mediated Protein Transport 
Drs2p was first implicated in vesicle-mediated protein transport by a genetic 
screen for mutants defective in ARF-dependent vesicle biogenesis (Chen et al., 1999). 
ARF (ADP-ribosylation factor) is a small GTP-binding protein that regulates coat protein 
assembly on transport vesicles (Randazzo et al., 2000; D'Souza-Schorey and Chavrier, 
2006). ARF acts as a molecular switch by cycling between active GTP-bound and 
inactive GDP-bound forms. The GDP-bound form is largely soluble, whereas the 
GTP-bound form exposes its myristoylated N-terminus and associates with the membrane 
via both the myristoyl group and several hydrophobic and basic residues from the 
N-terminal α-helix. Binding and hydrolysis of GTP by ARF require catalytic assistance 
from two classes of proteins. Guanine nucleotide exchange factors (GEFs) promotes the 
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exchange of GDP for GTP, while GTPase-activating proteins (GAPs) stimulate the 
hydrolysis of GTP by ARF to form GDP.  
In yeast Saccharomyces cerevisiae, ARF is encoded by two genes, ARF1 and 
ARF2, which are 96% identical in sequence and redundant in function. Single deletion of 
either gene has little effect on cell growth, but strains with the double deletion are 
inviable (Stearns et al., 1990a). In wild type cells, Arf2p is only expressed at 10% of the 
level of Arf1p, and arf2Δ shows a wild-type phenotype. However, arf1Δ exhibits partial 
defects in protein secretion and Golgi-specific glycosylation, and the morphology of 
Golgi and endosomes is substantially changed in arf1Δ mutants (Stearns et al., 1990b; 
Gaynor et al., 1998). 
The critical role of ARF in protein trafficking is to directly bind and recruit 
vesicle coats, which then capture cargos on the donor membrane and drive the formation 
of transport vesicles. ARF-dependent coats include the COPI coatomer complex, 
clathrin/adaptor protein (AP)-1, clathrin/GGA (Golgi associated, γ-ear homologous, ARF 
interacting) proteins, AP-3 and AP-4 complexes. COPI vesicles participate in the 
intra-Golgi transport and the retrograde transport from the Golgi complex to the 
endoplasmic reticulum (ER), whereas clathrin coated vesicles (CCV) mediate protein 
traffic from the plasma membrane to endosomes and between the trans-Golgi network 
(TGN) and endosomes. The polyhedral clathrin coats are assembled from triskelions, 
which are three-legged structures consisting of three clathrin heavy chains and three light 
chains (Brodsky et al., 2001). The interaction between the clathrin basket and the 
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membrane surface of the vesicle is mediated by adaptor proteins, which also facilitate 
cargo selection and bind additional accessory proteins (Robinson, 2004). A number of 
different adaptor proteins have been discovered to date, among which AP-1 and GGA are 
two major classes of adaptors that function in clathrin-mediated transport between the 
TGN and endosomes. While GGA proteins are monomeric adaptors, AP-1 is composed of 
two large subunits (β1 and γ), one medium subunit (μ1), and a small subunit (σ1). AP-3 
and AP-4 are heterotetrameric complexes with homology to AP-1, but they appear to be 
able to function independently of clathrin. AP-3 is involved in protein transport from 
endosomes and the TGN to lysosomes. AP-4, absent in yeast, has been implicated in 
sorting of cargos destined for lysosomes and the basolateral membrane in different cell 
types. 
The fact that a single ARF protein is involved in multiple protein transport 
pathways suggests that other regulators exist to coordinate its function. To better 
understand the function of ARF in vivo, the Graham lab performed a genetic screen for 
mutant alleles that displayed synthetic lethality with arf1Δ. This genetic interaction often 
implies that the two gene products involved play roles in the same pathway or in parallel 
pathways. Seven complementation groups were discovered in the screen and named 
SWA1-7 for synthetic lethality with arf1Δ. SWA5 was identified as clathrin heavy chain 
gene (CHC1), providing the first genetic evidence for a functional interaction in vivo 
between ARF and clathrin (Chen and Graham, 1998). SWA2 encodes a DnaJ protein and 
is the yeast ortholog of auxilin, a clathrin binding protein that recruits Hsc70p via its 
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DnaJ domain to uncoat CCVs (Gall et al., 2000). SWA7 is allelic to NMT1, which 
encodes the yeast N-myristoyltransferase (Our unpublished data). Myristoylation of the 
N-terminus of ARF is critical for its function. Unexpectedly, SWA3 and SWA4 were found 
to be allelic to DRS2 and CDC50 respectively (Chen et al., 1999; Chen et al., 2006). 
Drs2p and Cdc50p were later shown to be required for clathrin function in the TGN-early 
endosome system. Thus, most of the genes identified so far from this genetic screen are 
involved in regulation of clathrin dynamics, demonstrating that the screen is biased 
towards clathrin function.  
Drs2p localizes to the late Golgi and early endosomal membranes, where CCVs 
are actively budded.  drs2Δ is synthetically lethal with arf1 and chc-ts alleles and 
exhibits a marked reduction in CCVs isolated from subcellular fractions (Chen et al., 
1999). Similar to clathrin mutants, drs2Δ accumulates swollen Golgi cisternae and 
mislocalizes the TGN resident protein Kex2p, which normally cycles between the TGN 
and endosomal compartments to maintain its steady-state localization. Therefore, clathrin 
and Drs2p seem to participate in the protein traffic between the TGN and endosomes. In 
yeast, protein transport to the plasma membrane is mediated by two classes of exocytic 
vesicles, which are distinguished by density and cargos. Specifically, both clathrin and 
Drs2p are required for the formation of the dense exocytic vesicles which carry invertase 
and acid phosphatase (Gall et al., 2002). Moreover, Drs2 has genetic interactions with 
Gcs1, an ARF-GTPase activating protein, and physically associates with Rcy1, an F-box 
protein involved in recycling of cargo from the early endosome back to the TGN (Sakane 
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et al., 2006; Furuta et al., 2007). A role for Drs2p in the early endosome to TGN pathway 
has been proposed but still needs further investigation. In summary, most available data 
imply that Drs2p functions to facilitate CCV formation from the TGN and endosomal 
membranes.  
A drs2 allele bearing a truncation of the carboxyl terminal cytosolic tail (C-tail) 
can not complement the cold-sensitive growth and trafficking defects of drs2Δ, 
suggesting that the C-tail makes an essential contribution to Drs2 function (Chantalat et 
al., 2004; Liu et al., 2007). Three motifs have been mapped within the Drs2 C-tail thus 
far. The Gea2p interaction motif (GIM) directly interacts with the catalytically important 
Sec7 domain of the ARF-GEF Gea2p (Chantalat et al., 2004). Adjacent to GIM, there is a 
region highly conserved among all, including mammalian, Drs2p homologues. Function 
of this conserved motif is still unknown, although deletion of this motif abrogates 
function in vivo, suggesting that the conserved motif is primarily responsible for the 
essential function of the C-tail (Chantalat et al., 2004). At the membrane distal end of the 
C-tail there are two NPFX(1,2)D motifs, which are potential endocytosis signals (Tang et 
al., 1996; Valdivia et al., 2002). How the C-tail contributes to the function of Drs2p is 
still not clear, but it likely mediates protein interactions and/or TGN localization. 
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Figure 1-3: Vesicle-mediated protein-transport pathways that require Drs2p family 
P4-ATPases. (From Graham, 2004)  
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Studies have been done to determine if other members of yeast P4-ATPase family 
participate in protein traffic. NEO1 is essential for viability, so conditional alleles of 
NEO1 were isolated and studied (Hua and Graham, 2003; Wicky et al., 2004). After 
shifting to nonpermissive temperatures, neo1-ts mutants show several defects in common 
with COPI mutants, including a cargo-specific defect in secretion, aberrant glycosylation 
of cargo in the Golgi and mislocalization of Rer1-GFP to vacuole (Hua and Graham, 
2003). Rer1p is an integral membrane protein that continuously cycles between the ER 
and the Golgi. These data, in combination with the synthetic lethality between neo1-ts 
and COPI mutations, suggest that Neo1p is required for a retrograde transport pathway 
from the Golgi to the ER. In another study, neo1-ts mutants exhibited fragmented vacuole 
and defects in endocytosis (Wicky et al., 2004). Deletion of ARL1, an ARF like protein 
that functions within the endosomal/Golgi system, rescues the temperature sensitivity of 
neo1-ts. In addition, Neo1p have genetic and physical interactions with Ysl2p, a potential 
guanine nucleotide exchange factor for Arl1p. Thus, Neo1p seems to also play a role in 
protein traffic within the endosomal/Golgi system. 
Snc1p is an exocytic v-SNARE, which cycles in the TGN -> plasma membrane -> 
early endosome ->TGN pathway, but primarily localizes to the plasma membrane at 
steady-state. Disruption of DNF1 and DNF2 causes accumulation of Snc1p in internal 
membranes but has no affect on the trafficking of Ste2p, the a-factor receptor, which 
travels the endocytic pathway to the vacuole for degradation (Hua et al., 2002). Therefore, 
Dnf1p and Dnf2p play overlapping roles in an early endosome to TGN pathway. 
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Interestingly, dnf1Δ dnf2Δ mutant also displays a cold-sensitive defect in the 
internalization step of endocytosis, which is exacerbated by additional deletion of DRS2 
(Pomorski et al., 2003). Deletion of both DNF1 and DRS2 abrogates transport of alkaline 
phosphatase to the vacuole, whereas the dnf1Δ or drs2Δ single mutants transport alkaline 
phosphatase relatively normally (Hua et al., 2002). Thus, Dnf1p and Drs2p have 
redundant functions in this AP-3 mediated TGN to vacuole pathway. Remarkably, 
members of Drs2p family participate in all the protein transport pathways, in which ARF 
seems to be involved.  
 
Objectives of This Study 
The above evidence suggested that P4-ATPases function as a phospholipid 
translocases, and are important for establishing membrane asymmetry. These ATPases 
also play a critical role in vesicle mediated protein trafficking. The mechanism for 
coupling a specific P4-ATPase to specific transport pathways requires the appropriate 
localization and regulated local interactions. However, the precise mechanism that 
P4-ATPases use in facilitating vesicle biogenesis is unclear.  
In Chapter II of this thesis, the trafficking itineraries of Drs2p and Dnf1p are 
determined by studying the location of these proteins in various mutants defective for 
different trafficking pathways. Multiple endocytosis signals were defined in Drs2p, 
including two NPFXDs near the C-terminus and PEST-like sequences near the 
N-terminus for ubiquitin (Ub)-dependent endocytosis. Surprisingly, in a mutant that is 
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constitutively defective for Ub-dependent endocytosis but not for NPFXD-dependent 
endocytosis, Drs2p must be internalized through the NPFXD/Sla1p pathway to sustain 
viability. Thus, Drs2p seems to be an essential endocytic cargo for the NPFXD/Sla1p 
system.  
In Chapter III, we examined which clathrin adaptors Drs2p preferentially acts in 
conjunction with, and found that Drs2p and AP-1/clathrin function together in a 
TGN-early endosome pathway distinct from the TGN to late endosome pathway 
mediated by GGA/clathrin. A physical interaction was observed between Drs2p and AP-1. 
However, deletion of DRS2 does not seem to affect recruitment of AP-1 to the TGN 
membrane, suggesting that Drs2p is required at late stages in clathrin-coated vesicle 
formation. Interestingly, disruption of AP-1 alters Drs2p trafficking but not its 
steady-state localization to the TGN, demonstrating that Drs2p is a cargo of AP-1 
specifically for the anterograde TGN to early endosome pathway.  
Based on these observations, we propose that at the TGN, Drs2p facilitates 
formation of vesicles coated with clathrin and AP-1 by generating positive membrane 
curvature. Drs2p embarks within these AP-1/clathrin-coated vesicles for delivery to the 
early endosome, but uses an AP-1 independent pathway for retrieval back to the TGN.  
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CHAPTER II 
 
YEAST P4-ATPASES DRS2p AND DNF1p ARE ESSENTIAL CARGOS OF THE 
NPFXD/SLA1p ENDOCYTIC PATHWAY 
 
(This Chapter was previously published on: 
Molecular Biology of the Cell, Vol.18, 487-500, Feb 2007) 
 
Introduction 
Drs2p is a resident P-type ATPase of the yeast trans-Golgi network (TGN) that 
is required for vesicle-mediated protein transport from this organelle.  Most well 
characterized P-type ATPases are cation pumps that control the concentration of ions in 
both intracellular and extracellular spaces (for example, the Na+/K+ ATPase, Ca++ ATPase, 
and H+/K+ ATPase) (Kuhlbrandt, 2004). Drs2p, in contrast, is the founding member of a 
large P-type ATPase subfamily, called P4-ATPases (Catty et al., 1997), that are proposed 
to translocate phospholipid rather than ions. This flippase activity is responsible for 
translocating specific phospholipid molecules from the exoplasmic leaflet to the cytosolic 
leaflet to establish asymmetry of the membrane bilayer (Pomorski et al., 2003; Graham, 
2004; Pomorski et al., 2004; Paulusma and Oude Elferink, 2005; Devaux et al., 2006).  
For Drs2p, ATPase activity and presumably phospholipid translocation are essential, 
because mutation of the aspartic acid that forms an aspartyl-phosphate intermediate 
during catalysis (D560N) renders Drs2p nonfunctional in vivo (Chen et al., 1999).  In 
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addition, after shifting to the nonpermissive temperature, a drs2 temperature-sensitive (ts) 
allele causes a rapid loss of exocytic vesicle formation in vivo (Gall et al., 2002) and the 
loss of an ATP-dependent phosphatidylserine (PS) flippase activity in purified Golgi 
membranes containing Drs2-ts (Natarajan et al., 2004). Mammalian homologues of 
Drs2p include the chromaffin granule ATPase II (now called ATP8A1) (Tang et al., 1996), 
which is likely responsible for a PS translocase activity observed with these exocytic 
vesicles (Zachowski et al., 1989), and FIC1 (ATP8B1), for which mutations in humans 
cause an impairment of bile flow through the liver (cholestasis) (Bull et al., 1998; Klomp 
et al., 2004).  In addition, deletions removing the mouse Atp10c gene cause diet-induced 
obesity and type 2 diabetes phenotypes (Dhar et al., 2004b). P4-ATPases are also 
agriculturally important, as they are required for pathogenesis of the rice blast fungus 
Magneporthe griseus (Balhadere and Talbot, 2001; Gilbert et al., 2006) and growth of 
plants at cold temperatures (Gomes et al., 2000).   
The yeast Drs2p family of P4-ATPases, including Neo1p, Dnf1p, Dnf2p and 
Dnf3p, are all involved in protein transport in the secretory and endocytic pathways, but 
at different stages (Graham, 2004).  Drs2p and the Dnf proteins form an essential group 
and at least one of these proteins must be present to sustain yeast viability.  The 
Drs2/Dnf P4-ATPases have both overlapping and non-overlapping functions in protein 
transport (Hua et al., 2002). Strains carrying a deletion of DRS2 (drs2∆) are viable, but 
strongly cold-sensitive for growth, and exhibit defects in forming one of the two classes 
of exocytic vesicles (high density) targeted to the plasma membrane (Gall et al., 2002). 
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The drs2∆ mutant also exhibits defects in protein trafficking between the TGN and early 
endosome that are comparable to clathrin mutant phenotypes (Chen et al., 1999; Hua et 
al., 2002).  Thus, the Dnf ATPases cannot compensate for loss of Drs2p in these 
pathways and moreover, deletion of all three DNF genes does not perturb these 
Drs2p-dependent pathways.  Dnf1p and Dnf2p are 69% identical in amino acid 
sequence, localize to the plasma membrane and internal membranes (TGN, early 
endosomes and transport vesicles), and have redundant functions in the internalization 
step of endocytosis (at cold temperatures) and an early endosome to TGN transport 
pathway traveled by the Snc1p soluble N-ethylmaleimide-sensitive factor attachment 
protein receptor (SNARE) (Hua et al., 2002; Pomorski et al., 2003). Drs2p is also 
required for Snc1p recycling suggesting that Drs2p and Dnf1,2p are partially redundant 
in the this pathway. In addition, Drs2p and Dnf1p have redundant functions in the 
AP-3-dependent transport of alkaline phosphatase from the TGN directly to the vacuole.  
The individual drs2∆ or dnf1∆ mutants show little to no defect in the AP-3 pathway while 
this pathway is blocked in the drs2∆ dnf1∆ double mutant (Hua et al., 2002).  The 
mechanism for coupling a specific P4-ATPase to a specific protein transport pathway is 
unclear, but likely involves translocation substrate specificity, unique protein interactions 
and appropriate localization.   
Localization of Drs2p to the Golgi requires interaction with the Cdc50p 
chaperone subunit in order for the Drs2p/Cdc50p complex to exit the ER (Saito et al., 
2004). In cdc50∆, Drs2p is retained in the ER and these cells show protein transport 
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defects at the TGN comparable to drs2∆ (Chen et al., 2006).  Similarly, the Cdc50p 
homolog Lem3p (also called Ros3p) is required for transport of Dnf1p and presumably 
Dnf2p to the plasma membrane and so lem3∆ phenocopies dnf1∆ dnf2∆ (Saito et al., 
2004).   The Drs2p carboxyl-terminal cytosolic tail (C-tail) makes an essential 
contribution to its function, apparently by mediating protein interactions and/or TGN 
localization. Drs2p is linked to the vesicle budding machinery by a direct interaction 
between the ARF-GEF Gea2p and a short motif in the C-tail (called GIM, for Gea2p 
interaction Motif) (Chantalat et al., 2004). Adjacent to GIM, there is a region highly 
conserved among all, including mammalian, Drs2p homologues. Function of this 
conserved motif (CM) is still unknown, although a mutational analysis suggested that the 
CM is primarily responsible for the essential function of the C-tail (Chantalat et al., 2004). 
At the membrane distal end of the C-tail there are two NPFX(1,2)D motifs (hereafter 
referred to as NPFXD), which are potential endocytosis signals (Tang et al., 1996; 
Howard et al., 2002).  
In yeast, two types of endocytosis signals have been characterized that recruit 
membrane proteins into a clathrin/actin-based endocytic pathway for internalization from 
the plasma membrane: sequences that mediates phosphorylation and ubiquitination of 
cargo, such as PEST-like sequences, and the NPFXD motif (Tang et al., 1996; Howard et 
al., 2002; Wang et al., 2003).  The NPFXD signal is recognized by the Sla1p subunit of 
an endocytic coat complex consisting of clathrin, Pan1p, End3p, Sla2p/End4p (related to 
mammalian Hip1R) and Sla1p (related to mammalian  CIN85 and intersectin) (Tang et 
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al., 1996; Howard et al., 2002; Newpher et al., 2005; Kaksonen et al., 2006). Pan1p, a 
member of the Eps15 family of modular scaffolding proteins, interacts with the clathrin 
binding proteins AP180 and epsin, and also binds to and stimulates the ARP2/3 complex 
(Wendland and Emr, 1998; Duncan et al., 2001; Aguilar et al., 2003).  Therefore, Pan1p 
has the capacity to link adaptor-bound cargo proteins to clathrin-coated pits and sites of 
actin assembly. Pan1p, End3p and actin assembly are required for both ubiquitin 
(Ub)-dependent and NPFXD-dependent endocytosis, although Sla1p is only required for 
endocytosis of cargo bearing the NPFXD signal (Howard et al., 2002; Miliaras et al., 
2004).  Not only does Drs2p have the potential to physically interact with the 
Sla1p/Pan1p/End3p complex, it is also functionally linked to this complex as drs2∆ is 
synthetically lethal with the temperature-conditional pan1-20 allele (Chen et al., 1999).  
However, the nature of these relationships between Drs2p and this endocytic complex is 
unclear. 
Drs2p exhibits a steady-state localization to the TGN, although recent reports 
showed accumulation of Drs2p on the plasma membrane of a verprolin (vrp1) mutant and 
the presence of Drs2p in exocytic vesicles, suggesting that Drs2p transits the plasma 
membrane as part of its trafficking itinerary (Saito et al., 2004; Alder-Baerens et al., 
2006).  Dnf1p also appears to cycle between the exocytic and endocytic pathways (Hua 
et al., 2002; Saito et al., 2004). In this work, we further examined the trafficking itinerary 
of Drs2p and Dnf1p and tested whether the NPFXD motifs contribute to the function and 
localization of these P4-ATPases.  
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Materials and Methods 
 
Media and Strains  
Yeast were grown in standard rich medium (YPD) or synthetic defined (SD) 
minimal media containing the required nutritional supplements (Sherman, 1991). Yeast 
transformations were performed using the lithium acetate method. Escherichia coli 
strains DH5α and XL1-Blue were used for plasmid construction and amplification.  
Yeast strains used in this study are summarized in Table 2-1. The yeast knockout 
strain collection was originally purchased from Research Genetics (Huntsville, AL), 
which is now Resgen, Invitrogen Corporation (Carlsbad, CA). Strains carrying multiple 
disruptions were generated by standard genetic crosses and tetrad dissection. The 
genotype of each spore was determined by a PCR method as described by the 
Saccharomyces genome deletion project (http://sequence-www.stanford.edu/group/yeast_ 
deletion_project/deletions3.html). Strains expressing Myc and HA tagged Dnf1p were 
generated by PCR-based targeting into BY4741 and BY4741 sla1∆ using 
pPF6a-13Myc-HisMX6 or pPF6a-3HA-HisMX6 as the PCR template (Longtine et al., 
1998). Transformants were selected on SD plates without histidine and the integrated tags 
were confirmed by PCR.   
 
Plasmid Construction 
Plasmids used in this study are listed in Table 2-2. To generate pGBT9-Drs2CT 
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used in the two-hybrid test, a BamHI fragment from pDHS279 (Chantalat et al., 2004) 
containing the Drs2p C-tail (amino acids 1230-1355) was cloned into the pGBT9 BamHI 
site, and the orientation was confirmed by PCR. PCR products used to generate DRS2 
C-tail truncation plasmids pRS315-Drs2-ΔCT, pRS315-Drs2-ΔEnd, 
pRS315-Drs2-ΔNPF2, pRS315-Drs2-ΔNPF and pRS315-Drs2-Δ1274 were produced 
using a forward primer (CAGCTGATATAGCTCTTGG) that anneals 5’ of an endogenous 
NcoI site in DRS2 and reverse primers with a stop codon and MluI site added to the 3’ 
end. PCR products were then used to replace the NcoI/MluI region of pRS315-DRS2. 
The DRS2 internal deletion mutant pRS315-Drs2-ΔCM was generated from the 
truncation plasmid pRS315-Drs2-Δ1274 with the C-terminal sequence added as a 
MluI/SalI PCR fragment. A megaprimer PCR method (Barik and Galinski, 1991) was 
used to introduce point mutations into the MscI/SalI fragment of the DRS2 gene to 
produce plasmids pRS315-Drs2-NPW1 and pRS315-Drs2-NPW2. Using similar methods, 
pRS315-Drs2-ΔGIM-NPW1,2 was generated from pSC33 (pRS315-Drs2-ΔGIM). 
Sequencing of the resulting plasmids indicated that the specific mutations were 
introduced with no additional mutations.  All other clones generated from the PCR 
fragments described below were also sequenced for confirmation.   
The full-length DNF1 gene was cloned by PCR amplification using primers 
JN01F (CTATGTAATCACCTACTTCCC) and GR02R (CTGGAGTGCTACATGAGCC) 
and subcloned into pRS416 after treating both the vector and PCR product with SpeI and 
HindIII. The SpeI/XhoI fragment of pRS416-DNF1 was inserted into SpeI/XhoI site of 
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pRS313 to produce pRS313-DNF1. Site-directed mutagenesis of DNF1 to produce 
pRS313-Dnf1-NAI was carried out in plasmid pRS313-DNF1 using the QuickChange 
protocol (Stratagene, La Jolla, CA). 
For construction of GFP-DRS2, a 1.3kb SpeI/ClaI fragment from pGOGFP 
(Cowles et al., 1997) consisting of the PRC1 promoter and GFP(S65T) was inserted into 
pRS416 to generate pRS416-GFP. The plasmid pRS315-DRS2 was used as a PCR 
template with primers SalI-Drs2-F (ACGTAGTCGACAATGACGACAGAGAAACCCC 
C) and Drs2-CT-R (CCCCTCGAGGTCGACGGTA) to generate a 3.7kb fragment that 
placed SalI sites at both the start and end of the DRS2 coding region. This fragment was 
subcloned into SalI site of pRS416-GFP, creating the plasmid pGFP-DRS2. To eliminate 
mutations produced by PCR, most of the DRS2 coding sequence in pGFP-DRS2 was 
further replaced by an AgeI/ClaI fragment from pRS315-DRS2. This form of GFP-DRS2 
fully complemented the cell growth defect of drs2Δ at 20°C. To generate C-terminal tail 
mutated GFP-DRS2 (pGFP-Drs2-ΔNPF2, pGFP-Drs2-ΔNPF or pGFP-Drs2-NPW1,2), 
PCR amplifications of different regions of DRS2 C terminus were used to replace the 
NheI/ClaI region of pGFP-DRS2. To generate N-terminal truncated GFP-DRS2 
(pGFP-Drs2-ΔN2 or pGFP-Drs2-ΔN3), primers Drs2ΔN2F 
(GATGAGATCTCATGAAAATCTATTTATGAGCAAT) or Drs2ΔN3F 
(GACTGAGATCTCGAGCAGTCAAGCCTCCC) were used with Drs2NR 
(GAACCACAGTTGGGGTATCAG) to produce fragments to replace the BglII region of 
pGFP-DRS2. To generate pGFP-Drs2-ΔN3-NPW1,2,  the 1.44kb NheI/ClaI fragment 
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from pGFP-Drs2-NPW1,2 was used to replace the corresponding sequence in 
pGFP-Drs2-ΔN3. The PRC1 promoter is stronger than the DRS2 promoter, and so to 
avoid accumulation of GFP-Drs2p in the ER (Saito et al., 2004),we co-transformed yeast 
strains with a multicopy vector carrying CDC50 (pRS425-CDC50).  
To generate pGFP-CDC50, pRS315-CDC50 was used as template with primers 
CDC50KpnIF (CGGTACCGTTTCATTGTTCAAAAGAGGTA) and CDC50KpnIR 
(CGGTACCCACAAATACCTACAGGCACTA) to produce a 1.2 kb fragment with KpnI 
sites at both ends of the CDC50 coding region.  The fragment was subcloned into the 
KpnI site of pRS416-GFP. 
 
Microscopy 
Cells were observed using an Axioplan microscope (Carl Zeiss, Thornwood, 
NY). Fluorescent images were captured with a charge-coupled-device camera and 
processed with Metamorph 4.5 software (Molecular Devices, Sunnyvale, CA). To 
visualize GFP-tagged proteins, cells were grown to early-mid logarithmic phase, 
harvested and resuspended in imaging buffer (10 mM Tris-HCl, pH 7.4, and 2% glucose). 
Cells were mounted on glass slides and observed immediately using a GFP (green) 
bandpass filter set.   
To study the kinetics of GFP-Drs2p transport to the plasma membrane, mid-log 
phase cells were collected and resuspended in SD medium containing 200 μM latrunculin 
A. Samples of cells were harvested at different time points and imaged.  To label 
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endosomes, we incubated cells in ice-cold SD medium containing 10 μg/ml FM4-64 
(Invitrogen) for 20 min. Cells were washed twice with cold medium without FM4-64 and 
then incubated for 30 min at 30°C before microscopic examination. 
 
Subcellular Fractionation and Immunological Methods  
For subcellular fractionation experiments, ~25 OD600 units of each strain were 
grown in YPD media to an OD600 of 0.5-1.0. The cells were harvested and converted to 
spheroplasts in HB buffer (1.4 M sorbitol, 50 mM KPi, pH 7.5, 10 mM NaN3, 10 mM 
NaF, 40 mM β-mercaotpethanol), by using 200 μg/ml Zymolyase 100T (MP Biomedicals, 
Irvine, CA) at 30°C for 30min. The spheroplasts were washed twice with HB buffer and 
lysed by resuspension in triethanolamine (TEA) lysis buffer (0.5 M sorbitol, 25 mM TEA, 
pH 8.0, 1 mM EDTA) containing 1x complete protease inhibitor cocktail (PIC) lacking 
EDTA (Roche Diagnostics, Basel, Switzerland). The extract was centrifuged at 400 x g 
for 5 min and the resulting supernatant at 9,000 x g for 15 min in a refrigerated 
microcentrifuge.  After each centrifugation step, the supernatant was transferred to a 
separate tube, and the pellet was resuspended in an equal volume of TEA lysis buffer 
supplemented with PIC.  SDS/urea buffer was added to 1X (20 mM Tris-HCl pH6.8, 4 
M urea, 0.05 mM EDTA, 0.5% β-mercaptoethanol, 2.5% SDS, 0.125% bromophenol 
blue), and the samples were heated at 65°C for 10 min before electrophoresis.  
Immunoblotting and immunofluorescence experiments were performed as 
described previously (Chen et al., 1999). The 9E10 mouse monoclonal c-Myc antibody 
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(Oncogene Research Products, Darmstadt, Germany) was used at 1:2000 for Western 
Blot and 1:100 for immunofluorescence. Polyclonal rabbit anti-Pma1p antibody was a 
gift from Amy Chang (University of Michigan, Ann Arbor, MI), and was used at 1:1000 
to detect Pma1p by Western Blot. Polyclonal rabbit anti-G6PDH antibody 
(Sigma-Aldrich, St. Louis, MO) was used at 1:10,000 dilutions. Alexa-594 goat 
anti-mouse IgG (Invitrogen) was used at 1:200 as secondary antibodies for 
immunofluorescence.  
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Table 2-1:Yeast strains used in chapter II  
Strain  Genotype Source 
BY4741 MATa his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 Research Genetics 
BY4742 MATα his3Δ1 leu2Δ0 ura3Δ0 lys2Δ0 Research Genetics 
BY4741 YBL007C BY4741 sla1Δ::KanMX6 Research Genetics 
KLY011 MATα  his3Δ1 leu2Δ0 ura3Δ0 lys2Δ0 sla1Δ::KanMX6 This study 
BY4742 YNL084C BY4742 end3Δ::KanMX6* Research Genetics 
KLY201 MATα his3Δ1 leu2Δ0 ura3Δ0 lys2Δ0 end3Δ::KanMX6 This study 
BY4742 YLR337C BY4742 vrp1Δ::KanMX6 Research Genetics 
BY4741 YPR173C BY4741 vps4Δ::KanMX6 Research Genetics 
BY4741 YNR006W BY4741 vps27Δ::KanMX6 Research Genetics 
ZHY615D1C MATa his3Δ1 leu2Δ0 ura3Δ0 lys2Δ0 drs2Δ::KanMX6 Hua et al., 2002 
ZHY615M2D MATα his3Δ1 leu2Δ0 ura3Δ0 lys2Δ0 drs2Δ::KanMX6 Hua et al., 2002 
ZHY2149D MATα his3Δ1 leu2Δ0 ura3Δ0 lys2Δ0 drs2Δ::KanMX6 
dnf1Δ::KanMX6 
Hua et al., 2002 
KLY041 BY4742 DNF1::13XMYC This study 
KLY054 KLY011 DNF1::13XMYC This study 
KLY035 MATα his3Δ1 leu2Δ0 ura3Δ0 drs2Δ::KanMX6 
sla1Δ::KanMX6 
This study 
SEY6210 MATα leu2-3,112 ura3-52 his3-Δ200 trp1-Δ901 lys2-801 
suc2-Δ9 
Robinson et al., 1988 
SEY6211 MATα leu2-3,112 ura3-52 his3-Δ200 trp1-Δ901 ade 
suc2-Δ9 
Robinson et al., 1988 
SEY6210 drs2Δ SEY6210 drs2Δ::TRP1 Chen et al., 1999 
TGY1907 MATα  leu2-3,112 ura3-52 his3-Δ200 trp1-Δ901 suc2-Δ9 
pan1-20  
Chen et al., 1999 
TGY1906 MATa leu2-3,112 ura3-52 his3-Δ200 trp1-Δ901 suc2-Δ9 
pan1-20 
Chen et al., 1999 
TGY1912 MATa leu2-3,112 ura3-52 his3-Δ200 trp1-Δ901 lys2-801 
suc2-Δ9 end4-1  
Chen et al., 1999 
ZHY823 MATα leu2-3,112 ura3-52 his3-Δ200 trp1-Δ901 suc2-Δ9 
 pan1-20 drs2Δ::TRP1 ( pRS416-DRS2) 
This study 
CCY2808 MATa leu2 ura3-52 his3 trp1-Δ901 ade2 ade3 
arf1Δ::HIS3 drs2-2 (pRS416-DRS2) 
Chen & Graham, 
1998 
YJF1165 MATa trp1-901 leu2-3,112 ura3-52 his3-200 gal4Δ 
gal80Δ LYS2::GAL1-HIS3 GAL2-ADE2 
met2::GAL7-lacZ 
James et al., 1996 
* An extragenic suppressor mutation was found in this strain. 
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Table 2-2: Plasmids used in chapter II 
Plasmid Description Reference or Source 
pRS416 GFP-SNC1 GFP-SNC1 URA3 CEN Lewis et al., 2000 
pGO41 GFP-ALP URA3 2　 Cowles et al., 1997 
pRS426-KEX2-GFP KEX2-GFP URA3 2  　  Gift from Tom Vida 
pSM1493 STE6-GFP URA3 2　 Kelm et al., 2004 
pRS315-DRS2 DRS2 LEU2 CEN Chen et al., 1999 
pDRS2(D560N) drs2(D560N) LEU2 CEN Chen et al., 1999 
pRS315-Drs2-∆CT drs2-∆1259-1355 LEU2 CEN Chantalat et al., 2003
pRS315-Drs2-∆End drs2-∆1337-1355 LEU2 CEN Chantalat et al., 2003
pRS315-Drs2-∆NPF2 drs2-∆1315-1355 LEU2 CEN Chantalat et al., 2003
pRS315-Drs2-∆NPF drs2-∆1310-1355 LEU2 CEN Chantalat et al., 2003
pRS315-Drs2-∆CM drs2-∆1274-1283 LEU2 CEN Chantalat et al., 2003
pSC33  
[pRS315-Drs2- GIM]　  
drs2-∆1250-1270 LEU2 CEN Chantalat et al., 2003
pRS315-Drs2-∆GIM-∆NP
F 
drs2-∆1250-1263, ∆1310-1355 LEU2 CEN This study 
pRS315-Drs2-NPW1 drs2(F1313W) LEU2 CEN This study 
pRS315-Drs2-NPW2 drs2(F1335W) LEU2 CEN This study 
pRS315-Drs2-NPW1,2 drs2(F1313W,F1335W) LEU2 CEN This study 
pRS315-Drs2-∆GIM-NPW
1,2 
drs2-∆1250-1270, F1313W, F1335W LEU2 CEN This study 
pGBT9-Drs2-CT DRS2(aa 1230-1355) TRP1 2　 This study 
pZH429  
[pGBT9-Drs2-CT∆NPF] 
DRS2(aa 1230-1310) TRP1 2　 This study 
pGBT9-Drs2-CT-NPW1,2 DRS2(aa 1221-1355, F1313W,F1335W) TRP1 2　 This study 
pGBT9-Drs2-CT-∆GIM DRS2(aa 1221-1355, ∆1250-1263) TRP1 2　 This study 
pPAN1.1  
[Pan1-EH] 
PAN1(aa 96-713) TRP1 2　 Wendland and Emr, 
1998 
pGAD-SLA1-555 
[Sla1-SHD1] 
SLA1(aa 471-555) LEU2 2　 Gift from Gregory 
Payne Lab 
pGAD-SLA1charged 
[Sla1-Charged] 
SLA1(aa 511-855) LEU2 2　 Gift from Gregory 
Payne Lab 
pRS313-DNF1 DNF1 HIS3 CEN This study 
pRS313-Dnf1-NAI DNF1(PF147,148AI) HIS3 CEN This study 
pGOGFP CPY5’UTR-GFP URA3 2　 Cowles et al., 1997 
pRS416-GFP CPY5’UTR-GFP URA3 CEN This study 
pGFP-DRS2 CPY5’UTR-GFP-DRS2 URA3 CEN This study 
pGFP-Drs2-∆NPF2 CPY5’UTR-GFP-drs2 ∆1333-1355 URA3 CEN This study 
pGFP-Drs2-∆NPF CPY5’UTR-GFP-drs2 ∆1310-1355 URA3 CEN This study 
pGFP-Drs2-NPW1,2 CPY5’UTR-GFP-drs2(F1313W,F1335W) URA3 
CEN 
This study 
pGFP-Drs2-∆N2 CPY5’UTR-GFP-drs2∆1-72 URA3 CEN This study 
pGFP-Drs2-∆N3 CPY5’UTR-GFP-drs2∆1-103 URA3 CEN This study 
pGFP-Drs2-∆N3-NPW1,2 CPY5’UTR-GFP-drs2∆1-103(F1313W,F1335W) 
URA3 CEN 
This study 
pRS425-CDC50 CDC50 LEU2 2　 Chen et al., 2006 
pGFP-CDC50 CPY5’UTR-GFP-CDC50 URA3 CEN This study 
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Results 
 
The C-tail is Essential for Drs2p Function in Protein Transport 
Previously, we had shown that the ATPase dead drs2-D560N allele and a drs2 
allele bearing a truncation of the last 96 amino acids of the C-tail (drs2-ΔCT) could not 
complement the cold-sensitive growth defect of drs2Δ (Chen et al., 1999; Chantalat et al., 
2004). To test whether these alleles could complement trafficking defects of drs2Δ, we 
examined the localization of the exocytic v-SNARE Snc1p, which cycles between the 
plasma membrane, early endosomes and the TGN (Hettema et al., 2003). In wild-type 
cells, although a small fraction of GFP-Snc1p localizes to punctuate structures within the 
cell, GFP-Snc1p primarily localizes to the plasma membrane, concentrating in bud or the 
regions of polarized growth. In contrast, drs2Δ cells carrying an empty plasmid exhibited 
very little GFP-Snc1p at the plasma membrane and most of this fusion protein was found 
in internal structures, which may be either early endosomes or the TGN (Figure 2-1, 
empty; (Hua et al., 2002)). Introduction of a plasmid bearing wild-type DRS2 restored 
normal plasma membrane localization of GFP-Snc1p, but neither the drs2-D560N mutant 
nor the drs2-ΔCT allele were able to restore normal localization of GFP-Snc1p (Figure1; 
D560Ν, ΔCT).  
 48
  
 
 
Figure 2-1: ATPase activity and the C-tail region are essential for Drs2p function in 
protein trafficking.  
(A) Requirement for Drs2p ATPase activity and the C-tail region in Snc1p-GFP recycling. 
Plasmids pRS315 (empty), pRS315-DRS2 (DRS2), pDRS2-D560N (D560N, ATPase dead) 
and pRS315-Drs2-ΔCT (ΔCT) were introduced into strain ZHY615M2D (drs2Δ) along 
with pRS416-GFP-SNC1 (GFP-Snc1). Transformants were grown at 30°C to mid-log 
phase and examined by fluorescence microcopy. Snc1-GFP is at the plasma membrane of 
DRS2 (wild-type) cells and is trapped in internal membranes in the drs2 mutants.  
(B) Requirement for Drs2p ATPase activity and the C-tail region in alkaline ALP 
transport to the vacuole. The same DRS2 plasmids as in (A) were co-transformed into 
strain ZHY2149D (drs2Δdnf1Δ) with pGO41 (GFP-ALP). Cells were grown at 30°C to 
mid-log phase, shifted to 15°C for 2 h and then imaged. Fluorescent rings in the DRS2 
(wild-type) cells are vacuoles while GFP-ALP was mislocalized to extravacuolar puncta 
in drs2dnf1 mutants. 
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We also tested if these two drs2 mutant alleles could complement the alkaline 
phosphatase (ALP) trafficking defect shown by drs2Δ dnf1Δ cells. Drs2p and Dnf1p have 
redundant functions in the transport of GFP-ALP from the TGN to the vacuole (Hua et al., 
2002), a pathway mediated by AP-3 coated vesicles (Cowles et al., 1997).  In wild-type 
cells, GFP-ALP primarily localizes to the vacuole membrane, and one to three punctate 
structures outside of the vacuole in a small percentage of cells.  In drs2Δ dnf1Δ cells, 
however, most of the GFP-ALP localizes to extravacuolar puncta (Figure 2-1, empty; 
(Hua et al., 2002)). Wild-type DRS2 complemented this phenotype, but drs2-ΔCT and 
drs2-D560N failed to restore the normal vacuolar GFP-ALP localization pattern (Figure 
2-1; D560Ν, ΔCT). These results indicate that both the ATPase activity and the C-tail are 
critical for Drs2p function in protein trafficking from the TGN. 
 
Functional Requirement for the Drs2p NPFXD Motifs  
Three motifs have been mapped within the Drs2 C-tail thus far (Figure 2-2A), 
the Gea2p interaction motif (GIM), a highly conserved motif (CM) and the two NPFXD 
motifs, which could potentially interact with the Sla1p homology domain 1 (SHD1) of 
Sla1p (Howard et al., 2002). A two-hybrid analysis was done to test for an interaction 
between the Drs2p C-tail and the Sla1p SHD1 domain. The Eps15 homology (EH) 
domain of Pan1p interacts with NPF motifs (Wendland and Emr, 1998) and so the 
Pan1-EH domain was also tested for interaction with the Drs2p C-tail. The Drs2p C-tail 
gave a positive two-hybrid interaction with the Sla1p SHD1 domain but did not interact 
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with the Pan1p EH domain (Figure 2-2B). The Drs2p C-tail also failed to interact with a 
fragment of Sla1p containing the SHD2 domain and a number of charged amino acids 
(Fig 2-2B, Sla1-charged). Deletion of the C-terminal region containing the two NPFXD 
motifs abolished the two-hybrid interaction as did mutating both NPFXDs to NPWXD 
(Drs2-CT∆NPF and Drs2-CT-NPW). The F to W mutation was previously shown to 
disrupt the two-hybrid interaction of Sla1p with the NPFXD motif of Kex2p, and to 
disrupt the ability of this motif to serve as an endocytosis signal (Howard et al., 2002).  
In contrast, deletion of the C-tail GIM sequence had no effect on the interaction 
(Drs2-CT∆GIM). These data indicate that the interaction between Drs2p and Sla1p is 
mediated by the NPFXD motifs.  
As shown previously, deletion of the conserved motif (ΔCM) partially abrogated 
the ability of this drs2 allele to complement the cold-sensitive growth defect of drs2Δ, 
while deletion of both GIM and CM abolished Drs2p function.  In contrast, deletion of 
C-terminal sequences containing the NPFXD motifs (ΔNPF) did not appear to perturb 
Drs2p function or exacerbate the defect caused by ΔCM (Chantalat et al., 2004). These 
data initially suggested that the NPFXD motifs did not contribute to the essential function 
of the Drs2p C-tail. However, while neither deletion of the NPFXD motifs (∆NPF) nor 
deletion of GIM (∆GIM) perturbed complementation of the drs2Δ cold-sensitive growth 
defect, the ΔGIM-∆NPF double mutant failed to complement (Figure 2-2C).  These 
results indicate that the interaction with ARF-GEF and the C-terminal 44 residues bearing 
the two NPFXD motifs make important contributions to Drs2p function in vivo.   
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Figure 2-2: C-tail sequences containing the NPFXD motifs bind Sla1p and contribute to 
Drs2p function.
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Figure 2-2: C-tail sequences containing the NPFXD motifs bind Sla1p and contribute to 
Drs2p function.   
(A) Predicted topology and domain structure of Drs2p based on the crystal structure of 
the related sarcoplasmic reticulum Ca2+ ATPase ((A) actuator, (P) phosphorylation, (N) 
nucleotide binding) (Toyoshima and Inesi, 2004). Schematic diagram of motifs in the 
Drs2p C-tail and constructs used in this study ((GIM) Gea2p interaction motif, (CM) 
conserved motif).   
(B) Two-hybrid test for interaction between Drs2p C-tail and Sla1p SHD1 domain. Bait 
and prey plasmids used are described in Table 2-2. Serial dilutions of the cells were 
spotted on minimal medium with or without adenine (Ade).  Growth in the absence of 
adenine indicates a two-hybrid interaction.   
(C) Synergistic defect caused by deleting both the GIM and C-terminal 44 amino acids 
bearing the two NPFXD motifs. Serial dilutions of drs2∆ strains (ZHY615M2D) 
expressing the indicated constructs were tested for their ability to grow at 20°C. DRS2 is 
the wild-type gene and “empty” received the vector without an insert, thus showing the 
drs2∆ growth phenotype.   
(D) Western blot of cell lysates probed for Drs2p and clathrin light chain (Clc1p).  
Lysates were normalized for cell equivalents and compared to a dilution series from cells 
expressing wild-type DRS2.  
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 Figure 2-3: Mutation of Drs2p NPFXD motifs causes synthetic lethality with pan1-20. 
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Figure 2-3: Mutation of Drs2p NPFXD motifs cause synthetic lethality with pan1-20. 
(A) Serial dilutions of ZHY823 (drs2Δ pan1-20 pRS416-DRS2) expressing the indicated 
constructs from LEU2-based plasmids were tested for growth at 30°C on medium with or 
without 5-FOA. Failure to grow on the +5-FOA medium indicates synthetic lethality 
between pan1-20 and the drs2 allele expressed from the LEU2 plasmid.   
(B) The experiment shown in Figure 2-2C was repeated to include ∆GIM combined with 
the NPW point mutations.  
(C) The drs2-NPW1,2 allele is not synthetically lethal with arf1Δ. Serial dilutions of 
CCY2808 (arf1Δ drs2-2 pRS416-DRS2) expressing the indicated constructs from 
LEU2-based plasmids were tested for growth at 30°C on medium with or without 5-FOA. 
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To determine how mutations of the C-tail affect expression of Drs2p, we 
performed a Western Blot with whole cell lysates from the strains indicated in Figure 
2-2C. Most of the mutants were expressed at lower levels than wild-type Drs2p (DRS2), 
with ∆CT being most affected at significantly less than 10% expression (Figure 2-2D).  
However, co-expression of ΔCT and the ATPase dead D560N allele from two separate 
plasmids complements the cold-sensitive (cs) growth defect of drs2Δ, which indicates 
that this small amount of ΔCT provides sufficient ATPase activity to support Drs2p 
function reasonably well (Chantalat et al., 2004).  Importantly, all other C-tail mutant 
proteins were more stable than ΔCT. Therefore, while protein stability might be a factor 
that influences the ability of C-tail mutants to complement drs2∆, each mutant should 
supply sufficient Drs2p ATPase activity for in vivo function, and loss of specific sequence 
within the Drs2p C-tail is primarily responsible for reduced Drs2p function. Particularly 
relevant is the observation that ΔNPF and ΔGIM-∆NPF are expressed at a similar level, 
but the ΔGIM-∆NPF double mutant is much more defective than either single mutant 
(Figures 2-2C and 2D). 
Moreover, we were surprised to find that deletion of even one NPFXD motif was 
sufficient to cause synthetic lethality with pan1-20 (Figure 2-3A). For this experiment, 
viability of a drs2∆ pan1-20 strain was maintained by the presence of wild-type DRS2 on 
a URA3-based plasmid (pRS416-DRS2). Various mutant drs2 alleles were introduced into 
this strain on LEU2 plasmids and cells capable of losing the wild-type DRS2-URA3 
plasmid were selected on medium containing 5 fluoro-orotic acid (5-FOA). Growth in the 
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absence of 5-FOA shows the phenotype of the pan1-20 single mutant while the 5-FOA 
plate shows the drs2 pan1-20 double mutant phenotype. The drs2∆ (empty) and ∆CM 
alleles are synthetically lethal with pan1-20 although the ∆GIM allele is not. Deletion of 
the C-terminal 22 residues (∆End) had little effect on Drs2p function by this assay, but 
constructs bearing additional deletions removing one (∆NPF2) or both NPFXDs (∆NPF) 
failed to support growth of a pan1-20 drs2∆ strain. To better define the role of the 
NPFXDs in this genetic interaction, we mutated them to NPWXD. In this case, each 
individual drs2-NPW allele supported growth of the drs2∆ pan1-20 strain (NPW1 and 
NPW2), but the drs2-NPW1,2 double mutant (NPW1,2) failed to complement the drs2∆ 
pan1-20 synthetic lethality (Figure 3A). This allele-specific genetic interaction indicates 
that a yeast strain compromised for Pan1p activity relies on an NPFXD-dependent 
function of Drs2p to sustain life.   
Because the ∆NPF2 C-terminal truncations showed a stronger phenotype in the 
pan1-20 synthetic lethality test than the NPW2 point mutation, we considered the 
possibility that other sequences in the C-terminal 44 residues contribute to Drs2p function 
independently of the NPFXDs. This possibility was tested by combining the ∆GIM and 
NPW1,2 mutations (∆GIM-NPW1,2) and comparing the ability of this new allele to 
complement drs2∆ relative to the alleles used in Figure 2-2C. As shown in Figure 2-3B, 
the ∆GIM-NPW1,2 allele complemented the cs growth defect of drs2∆ while 
∆GIM-∆NPF again failed to complement. These data indicate that C-terminal 44 amino 
acids have an NPFXD-independent function that appears to act redundantly with the 
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Gea2p interaction motif (GIM). Alternatively, it is possible that the mutant NPW motif 
retains some function.  
To further test if the genetic interaction is specific to pan1-20, we also examined 
the synthetic lethality between drs2 mutants and arf1∆ (Figure 2-3C). As expected, the 
ATPase dead drs2-D560N allele failed to support growth of a drs2-2 arf1∆ strain. The 
drs2-ΔCT allele causes slow growth when combined with arf1∆ (data not shown), but 
drs2 alleles carrying deletions of CM, GIM or NPFXD motifs do not substantially perturb 
growth of arf1∆ cells. Therefore, the synthetic lethal interaction between drs2-npf alleles 
and pan1-20 is specific. 
 
Functional Requirement for the Dnf1p NPFXD Motif 
Interestingly, Dnf1p contains an NPFXD within its N-terminal cytosolic tail 
(N-tail) that is not present in the closely related Dnf2p. In addition, Dnf1p, but not Dnf2p, 
has redundant functions with Drs2p at the TGN, suggesting that the NPFXD-dependent 
endocytosis of Dnf1p may be required for its Golgi function. To test whether the NPFXD 
is important for Dnf1p function, we mutated NPF to NAI, the sequence found in Dnf2p 
(Figure 2-4A). Because there is no significant phenotype associated with deleting DNF1 
alone, we tested the dnf1-NAI allele for complementation of growth defects associated 
with the drs2∆ dnf1∆ double mutant. On minimal medium, drs2∆ dnf1∆ grows well at 
30˚C but is strongly cs and ts for growth (Figure 2-4B, empty). Transformation with 
wild-type DRS2 completely complements these growth defects (Figure 2-4B, DRS2), 
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showing the robust growth of a dnf1 single mutant. Transformation with wild-type DNF1 
allowed growth at 24˚C and 37˚C, although these drs2∆ DNF1 cells grew more slowly 
than the DRS2 dnf1∆ cells. In contrast, dnf1-NAI weakly complemented the cs growth 
defect and failed to complement the ts growth defect. Therefore, the NPFXD motif plays 
an important role in the ability of Dnf1p to compensate for the loss of Drs2p.  
If the important role of the Dnf1p NPFXD is for Sla1p-dependent endocytosis, 
then a drs2∆ sla1∆ mutant should show a more severe growth defect than drs2∆, similar 
to what was observed for drs2∆ dnf1-NAI. Deletion of SLA1 alone causes a ts growth 
defect; however, we could detect a slightly more severe growth defect of sla1∆ drs2∆ at 
37˚C (Figure 2-4C). However, the sla1∆ single mutant grows well at low temperatures. 
Therefore, we tested whether sla1∆ would exacerbate the cs growth of drs2∆ by using a 
slightly lower, more restrictive temperature than used in Figure 2-4B. Indeed, drs2∆ 
sla1∆ grew much more slowly at 23˚C than drs2∆ or sla1∆. Even though sla1∆ may have 
pleiotropic effects on trafficking of several proteins, the uniquely strong cs growth defect 
of drs2∆ dnf1∆ suggests the effect of sla1∆ we are scoring in this assay is reduced Dnf1p 
function.   
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Figure 2-4: An NPFXD/Sla1p interaction contributes to Dnf1p function and endocytosis. 
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Figure 2-4: An NPFXD/Sla1p interaction contributes to Dnf1p function and endocytosis.   
(A) Sequence alignment of Dnf1p and Dnf2p in the region surrounding the Dnf1p 
NPFXD motif.   
(B) Plasmids bearing wild-type DRS2 (pRS315-DRS2), DNF1 (pRS313-DNF1), empty 
vector and NPF to NAI mutated DNF1 (pRS313-Dnf1-NAI) were introduced into 
drs2Δdnf1Δ (ZHY2149D). Cell growth on minimal medium at 37°C, 30°C and 24°C was 
examined.   
(C) Growth of wild-type (BY4742), sla1∆ (KLY011), drs2∆ (ZHY615M2D) and sla1∆ 
drs2∆ (KLY035) was examined at 37°C, 30°C and 23°C.  
(D) Fluorescence microscopy of wild-type and sla1Δ cells expressing Dnf1-Myc and 
stained with a mouse monoclonal anti-Myc antibody. Arrowheads indicate regions of 
labeled plasma membrane.  
(E) Distribution of Dnf1p-HA between the plasma membrane and internal membranes. 
Wild-type, sla1Δ and end3Δcells expressing HA tagged Dnf1p were osmotically lysed 
and centrifuged at 400 x g to clear the cell debris. The supernatants were subsequently 
centrifuged at 13,000 x g for 15min to generate pellet (P) and (S) fractions. Samples from 
each fraction were immunoblotted for Dnf1p-HA, the plasma membrane H+-ATPase 
(Pma1p) and the Golgi protein Mnn1p. The arrow indicated a background protein that 
distributes in the S fraction. 
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NPFXD-dependent Endocytosis of Dnf1p and Drs2p 
To directly determine whether the endocytosis of Dnf1p was dependent on Sla1p, 
the localization of Dnf1p-Myc was examined in both wild-type and sla1∆ cells by 
indirect immunofluorescence (Figure 2-4D). In wild-type cells, Dnf1p-Myc is localized 
to both the plasma membrane and internal membranes with a polarized distribution, 
which could be transient endocytic and/or exocytic vesicles. Dnf1p is concentrated at the 
emerging bud site, small buds and the mother-daughter neck of dividing cells (Hua et al., 
2002; Pomorski et al., 2003); Figure 2-4D). Relative to wild-type cells, sla1∆ cells 
showed an accumulation of Dnf1p-Myc on the plasma membrane, although the change in 
the localization pattern was subtle by this method. To more quantitatively address the 
distribution of Dnf1p, a fractionation approach was used (Figure 2-4E). Cells expressing 
HA tagged Dnf1p were converted to spheroplasts, osmotically lysed, centrifuged at 400 X 
g to pellet unlysed cells and large membranes, and then centrifuged at 13,000 X g to 
produce pellet (P) and supernatant (S) fractions. In wild-type cells, most Dnf1p-HA was 
found in the S fraction, which was relatively devoid of plasma membrane as judged by 
the distribution of the plasma membrane H+-ATPase, Pma1p. However, with sla1Δ and 
end3Δ, the amount of Dnf1p-HA in the S fraction was diminished with a concomitant 
increase in the plasma membrane P fraction. As a control, the distribution of an integral 
membrane glycoprotein of Golgi complex, Mnn1p, was examined, and no difference was 
observed between wild-type and sla1Δ and end3Δ cells. Moreover, the HA-tagged 
Dnf1-NAI mutant showed a 1.4-fold increase in the pellet fraction relative to wild-type 
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HA tagged Dnf1p (our unpublished data). The end3Δ strain showed a more substantial 
redistribution of Dnf1o to the P fraction than sla1Δ or wild-type cells expressing 
Dnf1-NAI. In total, these experiments indicate that the NPFXD/Sla1p interaction 
significantly contributes to endocytosis of Dnf1p, but other endocytosis signals likely 
exist in this protein.  
Even though Drs2p localizes to the TGN with Kex2p (Chen et al., 1999), the 
fact that Drs2p contains two NPFXD motifs suggests that it might travel to the plasma 
membrane and get rapidly endocytosed by the NPFXD/Sla1p pathway to maintain a 
steady-state TGN localization. If this is the case, we would expect to see accumulation of 
Drs2p on the cell surface when either the NPFXD motifs were mutated or SLA1 was 
deleted. To test this hypothesis, wild-type or NPFXD mutated GFP-Drs2 fusion proteins 
were expressed in either wild-type or sla1Δ cells (Figure 2-5). The GFP-DRS2 construct 
used here fully complements the drs2∆ cs growth defect and localizes appropriately to 
the TGN based on its co-localization with Sec7-RFP (Chen et al., 2006). We fused GFP 
to the N-terminus of Drs2p to avoid interference with the potential trafficking signals 
near the C-terminus. Surprisingly, neither truncation of the C-terminal region containing 
the two NPFXD motifs (GFP-ΔNPF) nor mutation of both NPFXD motifs to NPWXD 
(GFP-NPW1,2) caused accumulation of Drs2p on the plasma membrane of wild-type 
cells (Figure 2-5, WT). Similar results were obtained for sla1Δ cells, with neither the 
wild-type nor the ∆NPFXD GFP-Drs2p being mislocalized (Figure 2-5, sla1∆).  
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Figure 2-5: Drs2p does not rely on its NPFXDs and Sla1p for endocytosis unless the 
endocytic machinery is compromised.   
A series of plasmids harboring GFP tagged wild-type (pGFP-DRS2) or NPFXD mutated 
drs2 alleles (pGFP-ΔNPF2, pGFP-ΔNPF, pGFP-NPW1,2) were co-transformed with 
pRS425-CDC50 into wild-type (BY4742), sla1Δ (KLY011) or end3Δ (BY4742 
YNL084C) cells. Transformants were grown to early-log phase at 30 °C and imaged by 
fluorescence microscopy at room temperature.  Arrowheads indicate plasma membrane 
fluorescence.  
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       To test whether Drs2p trafficked to the plasma membrane and was retrieved by 
endocytosis signals other than NPFXD motifs, we expressed GFP-Drs2p in cells carrying 
a disruption of END3 (end3Δ), which should elicit an efficient block in endocytosis of all 
proteins that transit the cell surface. Only a modest amount of wild-type GFP-Drs2p was 
trapped on the end3Δ plasma membrane, most noticeably in small buds of a small 
percentage of cells (arrowheads Figure 2-4, end3Δ, GFP-Drs2). Surprisingly, we found 
that deletion of one NPFXD motif (GFP-ΔNPF1) caused substantial accumulation of 
Drs2p on the end3Δ cell surface. Further truncation to remove the second NPFXD motif 
(GFP-ΔNPF) exacerbated this phenotype. Mutation of both NPFXDs to NPWXDs also 
resulted in accumulation of GFP-Drs2p on the end3Δ plasma membrane (Figure 2-5). 
These results were unexpected and suggested that Drs2p did not normally travel 
to the plasma membrane, but deletion of the NPFXD motifs caused mislocalization of 
Drs2p to the plasma membrane where it could be trapped behind the end3 block. This 
was, however, contradictory to a published report showing Drs2p-GFP accumulates on 
the plasma membrane upon deletion of verprolin (vrp1∆), a protein required for proper 
organization of cortical actin patches and the internalization step of endocytosis (Saito et 
al., 2004). In addition, NPFXD-mediated endocytosis reportedly requires End3p function 
(Tang et al., 1996). To resolve these discrepancies, we examined localization of 
GFP-Drs2 in vrp1Δ as well as end4-1 (also known as sla2), another endocytosis mutant. 
GFP-Drs2 accumulated at the plasma membrane of both vrp1∆ and end4-1 cells (Figure 
2-6), in agreement with previously published vrp1∆ data (Saito et al., 2004). This result 
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led us to suspect that the end3Δ strain from the yeast knockout collection contained an 
extragenic suppressor that specifically restored function of the NPFXD/Sla1p pathway. 
By backcrossing the original end3Δ strain to wild-type cells, new end3Δ strains were 
isolated that exhibited a tighter temperature-sensitive growth phenotype. Using a 
backcrossed end3Δ strain (KLY201), wild-type GFP-Drs2 was readily detected on the 
plasma membrane (Figure 2-6).   
The observation that GFP-Drs2p localizes to the TGN in wild-type cells, but 
accumulates on the plasma membrane of end3, vrp1 and end4 suggests that Drs2p cycles 
between the exocytic and endocytic pathways. Neither deletion of SLA1, nor deletion of 
the Drs2-NPFXD motifs led to accumulation at the plasma membrane.  Therefore, 
Drs2p must contain a second endocytosis signal that acts independently of Sla1p, but 
requires the actin-based endocytic machinery.  Because GFP-Drs2p was only trapped on 
the plasma membrane of the original end3∆ strain when the NPFXD motifs were mutated, 
this strain must contain an extragenic mutation that suppresses Sla1p/NPFXD-mediated 
endocytosis but does not suppress end3∆ defects in endocytosis mediated by other signals. 
Thus, the original end3Δ strain (BY4742 end3∆) was useful because it demonstrated an 
active role for the Drs2p NPFXD motifs in endocytosis.  
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Figure 2-6: Localization of GFP-tagged Drs2p to the plasma membrane of endocytosis 
mutants.  
pGFP-DRS2 was co-transformed with pRS425-CDC50 into wild-type (BY4742), vrp1Δ 
(BY4742 YLR337C), end3Δ (KLY201) and end4-1 (TGY1912) cells. Transformants 
were grown to early-log phase at 27°C and examined by fluorescence microscopy. 
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Figure 2-7: The pan1-20 mutant exhibits a constitutive defect in Ub-dependent 
endocytosis and a temperature conditional defect in NPFXD-dependent endocytosis. 
(A) Localization of GFP-Drs2p and GFP-Drs2-NPW1,2p in pan1-20 (TGY1906) cells. 
This pan1-20 strain expresses wild-type Drs2p from its endogenous locus to support 
viability. Cells were grown to mid-log phase at 27°C with or without shifting to 37°C for 
1 h before imaging. Arrowheads indicate plasma membrane fluorescence.  
(B) Ste6p-GFP localization in wild-type and pan1-20 cells at 27°C. Wild-type (SEY6211) 
and pan1-20 (TGY1906) cells transformed with a plasmid harboring Ste6p-GFP 
(pSM1493) were grown at 27°C to mid-log phase and examined by fluorescence 
microscopy. Arrows indicate vacuoles. Arrowheads indicate plasma membrane 
fluorescence. 
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Cargo-selective Endocytosis Defect of pan1-20 
Mutation of both NPFXD motifs in Drs2p results in synthetic lethality with 
pan1-20 (Figure 2-3), suggesting that pan1-20 must maintain an active 
Sla1p/NPFXD-dependent endocytosis pathway at the permissive growth temperature. 
Otherwise, it is difficult to understand how mutation of an NPFXD endocytosis signal 
would further exacerbate growth of pan1-20. To test the Pan1p requirement for 
endocytosis of Drs2p, we examined the localization of GFP-Drs2p and 
GFP-Drs2-NPW1,2p in pan1-20 at the permissive (27˚C) and nonpermissive (37˚C) 
growth temperatures. GFP-Drs2p localized appropriately to the TGN at 27˚C, but in stark 
contrast, GFP-Drs2-NPW1,2p was primarily localized to the plasma membrane. After a 
1-h shift to 37˚C, both GFP-Drs2p and GFP-Drs2-NPW1,2p accumulated on the plasma 
membrane. Kex2-GFP, another TGN resident, did not accumulate on the plasma 
membrane of pan1-20 at either temperature (unpublished observations). These results 
indicate that at the permissive temperature, pan1-20 cells are defective in the 
Sla1p/NPFXD-independent endocytosis pathway but retain a functional 
Sla1p/NPFXD-dependent pathway. Both pathways are blocked at the nonpermissive 
temperature, causing accumulation of wild-type GFP-Drs2p at the plasma membrane.   
The Sla1p/NPFXD-independent endocytosis pathway blocked in pan1-20 at all 
temperatures is mostly likely dependent on Ub-dependent endocytosis signals. To test this 
possibility, we examined the localization of Ste6p-GFP in pan1-20 cells. Ste6p is a ABC 
transporter that uses a Ub-dependent signal for endocytosis (Kolling and Hollenberg, 
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1994; Kelm et al., 2004; Krsmanovic et al., 2005). In wild-type cells, Ste6-GFP 
accumulates in the vacuole over time and so the cells show primarily vacuolar patterns of 
fluorescence. However, Ste6-GFP accumulated at the plasma membrane of pan1-20 cells 
at 27˚C (Figure 2-7B). Thus, Ub-dependent endocytosis is abrogated in pan1-20 at 
permissive growth temperatures.   
 
Additional Endocytosis Signals in the Drs2p N-tail 
The dependence of Drs2p on its NPFXD signals for TGN localization in 
pan1-20 and end3∆ (suppressor) cells, but not wild-type cells strongly suggested that 
Drs2p must contain an additional endocytosis signal that is Ub dependent. A search for 
this signal using the PESTfind algorithm identified two “potential” and one “poor” PEST 
sequence along with 11 lysines in the N-tail of Drs2p (Figure 2-8A). Several other “poor” 
PEST sequences were found throughout Drs2p although none were in the C-tail. 
Deletions removing two (∆N2, amino acids 1-72) or all three possible PEST sequences 
(∆N3, amino acids 1-103) in the N-tail were constructed and the localization of 
GFP-Drs2-∆N proteins was examined in wild-type, sla1∆ and pan1-20 cells. As predicted, 
GFP-Drs2-∆N2 and GFP-Drs2-∆N3 were localized to the TGN in wild-type and pan1-20 
cells at 30 ˚C and mislocalized to the plasma membrane in sla1∆ cells (Figure 2-8B). 
Both GFP-Drs2-∆N2 and GFP-Drs2-∆N3 complemented the cs growth defect of drs2∆, 
indicating that this deletion did not perturb Drs2p ATPase activity or function in protein 
transport. These data indicate that Drs2p has an endocytosis signal(s) in the N-tail that is 
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recognized by components of the endocytic apparatus specifically disrupted by the 
pan1-20 mutation. Combining the ∆N3 and NPW mutations caused accumulation of a 
small amount of GFP-Drs2p on the plasma membrane of wild-type cells (Figure 2-8C). 
The localization of most Drs2-∆N3-NPW1,2 to intracellular compartments suggests that 
these mutations have not eliminated all of the endocytosis signals in Drs2p. In addition, 
the observation that Drs2-ΔN3-NPW1,2 does not accumulate on the plasma membrane as 
much as Drs2-ΔN3 expressed in slaΔ cells suggests that Sla1p contributes more to 
endocytosis than just the recruitment of NPFXD cargo. 
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Figure 2-8:  Sequences in the Drs2p N-tail bearing PEST-like motifs mediate 
endocytosis redundantly with the NPFXD motifs.  
(A) The N-tail of Drs2p contains two potential PEST sequences and one poor PEST 
sequence. Arrowheads indicate the N-terminal truncation boundaries for the 
GFP-DRS2-∆N2 and -∆N3 alleles.  
(B) Localization of the GFP-Drs2p with N-terminal truncations in wild-type, sla1∆ and 
pan1-20 cells. pGFP-DRS2, pGFP-Drs2-∆N2 and pGFP-Drs2-∆N3 were co-transformed 
with pRS425-CDC50 into wild-type (BY4742), sla1∆ (KLY011) or pan1-20 (TGY1907) 
cells. Transformants were grown to early-log phase at 30 °C and imaged by fluorescence 
microscopy at room temperature. Arrowheads indicate plasma membrane fluorescence.  
(C) Localization of the GFP-Drs2p with both the N-terminal truncation and the NPW1,2 
mutations in wild-type cells. pGFP-Drs2-∆N3-NPW1,2 was co-transformed with 
pRS425-CDC50 into wild-type cells. Transformants were grown to early-log phase at 30 
°C and imaged by fluorescence microscopy at room temperature.  Arrowheads indicate 
plasma membrane fluorescence. 
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Figure 2-9: Drs2p accumulates slowly on the plasma membrane after disrupting 
endocytosis.   
Wild-type cells expressing either GFP-Drs2p or Kex2p-GFP were grown to early-log 
phase at 30˚C and then incubated in SD medium containing 200 μM latrunculin A (Lat-A) 
or dimethylsulfoxide at 30°C for the times shown. Arrowheads indicate plasma 
membrane fluorescence. 
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Slow Exit of Drs2p from the TGN 
The vrp1 and end mutants used above are constitutively defective for 
endocytosis and so these studies do not indicate how frequently GFP-Drs2p travels to the 
plasma membrane. To determine the kinetics of GFP-Drs2p transport to the plasma 
membrane, wild-type cells expressing GFP-Drs2 were treated with latrunculin A (lat-A), 
an inhibitor of actin assembly and endocytosis, and imaged over time (Figure 2-9). After 
1 h of treatment, GFP-Drs2p was still primarily retained intracellularly in small puncta, 
although it could be detected on the plasma membrane (Figure 2-9, Lat-A 1 h). After 3 h 
of treatment, the cell surface GFP-Drs2p further increased, concomitant with a reduction 
in the intensity of GFP-Drs2p intracellular fluorescence, and approached the distribution 
observed in the end mutants (Figure 2-9, Lat-A 3 h). Actin assembles on Golgi 
membranes and so we considered the possibility that perturbation of actin caused 
mislocalization of all late Golgi proteins, comparable with clathrin mutants. Therefore, 
Kex2p-GFP was also examined in this experiment. Even when overexpressed, 
Kex2p-GFP did not show any plasma membrane staining after 3 h of lat-A treatment 
(Figure 2-9, Kex2-GFP). These data demonstrate that unlike Kex2p, another 
TGN-localizing, NPFXD-containing protein, Drs2p slowly cycles between the TGN and 
the plasma membrane.  
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Drs2p and Cdc50p Do Not Significantly Transit the Late Endosome 
Several different TGN proteins cycle through the late endosome as part of their 
normal trafficking itinerary (Wilcox et al., 1992; Nothwehr et al., 1993; Cooper and 
Stevens, 1996; Brickner and Fuller, 1997; Foote and Nothwehr, 2006). We tested if Drs2p 
transited through the late endosome/prevacuolar compartment (PVC) by examining its 
localization in class E vps mutants, which block protein and lipid transport out of the 
PVC and result in the formation of an enlarged endosomal compartment adjacent to the 
vacuole called the class E compartment (Conibear and Stevens, 1998). Proteins that 
traffic through the PVC accumulate in the class E compartment of vps4 or vps27 cells. 
We expressed GFP-Drs2p in vps4∆ or vps27∆ and labeled the class E compartments with 
the endocytic tracer FM4-64 (Vida and Emr, 1995)  before analysis by fluorescence 
microscopy. Although a small amount of GFP-Drs2 was detected in class E 
compartments at steady-state, the large majority of this protein did not colocalize with the 
FM4-64 and remained in small puncta (Figure 2-10A). In addition, we could not detect 
Drs2-Myc (C-terminal tag) in the class E compartment of vps27∆ by 
immunofluorescence (data not shown). 
The Drs2p chaperone Cdc50p has been described as a late endosomal protein 
because Cdc50-GFP (GFP fused to C-terminus of Cdc50p) accumulated in the class E 
compartment (Misu et al., 2003).  However, this phenotype does not discriminate 
between a TGN or endosomal protein, and is inconsistent with our observations with 
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GFP-Drs2p. Therefore, we examined the localization of GFP-Cdc50p (GFP fused to the 
N-terminus of Cdc50p) in the vps mutants.  This fusion protein is functional based on 
complementation of the cs growth defect of cdc50∆. However, we were unable to detect a 
significant amount of colocalization between FM4-64 and GFP-Cdc50 in the class E 
compartment of vps27∆ or vps4∆ cells (Figure 2-10B). Because neither GFP-Drs2p nor 
GFP-Cdc50p fluorescence collapsed into the class E compartments of either mutant, the 
PVC does not appear to be a significant destination in the trafficking itinerary of these 
proteins. We also considered the possibility that NPFXD motifs play a role in retrieval of 
Drs2p from early endosomes back to the TGN. If so, deletion of the NPFXD motifs may 
force Drs2p to transit through the PVC more frequently. To test this possibility, we 
examined localization of GFP-Drs2p-∆NPF and GFP-Drs2p-NPW in the vps cells. 
Neither GFP-Drs2p-∆NPF nor GFP-Drs2p-NPW accumulated in the class E 
compartments (our unpublished data), indicating that potential sorting signals that 
prevent Drs2p trafficking to the PVC do not lie in the last 44 amino acids.  
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 Figure 2-10: GFP-Drs2p and GFP-Cdc50p do not accumulate in the prevacuolar 
compartment of class E vps mutants. 
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Figure 2-10: GFP-Drs2p and GFP-Cdc50p do not accumulate in the prevacuolar 
compartment of class E vps mutants.  
vps27Δ and vps4Δ cells carrying pGFP-DRS2 and pRS425-CDC50 (A) or pGFP-CDC50 
and pRS425-DRS2 (B) were grown to early-middle log phase at 30˚C, labeled with10 
μg/ml FM4-64 on ice for 20 min, washed with fresh medium, and then chased at 30°C for 
30 min before analysis. GFP and FM4-64 images were acquired separately and merged to 
show the coincidence of the two patterns. Arrowheads indicate the prevacuolar 
compartment. 
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Discussion 
 
Trafficking of Drs2p and Dnf1p 
TGN-dwelling proteins have evolved different mechanisms to maintain their 
steady-state localization in this organelle, although transport to the endosomal system and 
retrieval back to the TGN appears to be a common theme.  Recycling mechanisms are 
critical for localization of Golgi proteins because a growing body of evidence indicates 
that Golgi cisternae are not stable structures but instead mature from cis to trans by 
changing the content of resident enzymes (Losev et al., 2006; Matsuura-Tokita et al., 
2006).  Cisternae mature with a half-time of 1 to 2 min in the yeast system and the TGN 
is apparently consumed into transport carriers with multiple destinations. Therefore, TGN 
resident proteins must recycle back to younger cisternae every few minutes to maintain 
Golgi residence. Some mammalian TGN proteins, such as the mannose-6-phosphate 
receptor, TGN38 and furin, cycle to the plasma membrane and endosomes before 
returning to the TGN. These proteins require endocytic signals for removal from the 
plasma membrane and retrograde sorting signals to mediate endosome to TGN transport 
(Thomas, 2002; Ghosh et al., 2003; Traub, 2005). In yeast, the vacuolar hydrolase sorting 
receptors Vps10p and Mrl1p rapidly cycle between the TGN and the late endosome / 
PVC (Cereghino et al., 1995; Cooper and Stevens, 1996; Andrew Nesbit et al., 2004).  
The TGN markers Kex2p and Ste13p are thought to primarily cycle between the TGN 
and early endosomes, occasionally transiting the PVC but not the plasma membrane 
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(Abazeed et al., 2005; Foote and Nothwehr, 2006).  
None of the yeast TGN proteins mentioned above accumulate on the plasma 
membrane when endocytosis is blocked (Cooper and Bussey, 1992; Roberts et al., 1992; 
Wilcox et al., 1992; Bryant and Stevens, 1997).  In contrast, most (but not all) Drs2p 
accumulates on the plasma membrane of mutants constitutively defective for endocytosis.  
However, acute inactivation of endocytosis by latrunculin A treatment of cells causes a 
rather slow accumulation of Drs2p on the plasma membrane over the course of ~3 h. 
These findings suggest that Drs2p is inefficiently incorporated into exocytic vesicles, and 
is rapidly endocytosed upon arrival at the plasma membrane.  The slow delivery to the 
plasma membrane and rapid endocytosis leads to an undetectable amount of Drs2p on the 
plasma membrane of wild-type cells unless endocytosis is inhibited. It is formally 
possible that disruption of endocytosis causes an aberrant incorporation of Drs2p into 
exocytic vesicles leading to plasma membrane accumulation. However, other TGN 
proteins do not share this fate in endocytosis mutants arguing against a reduced fidelity of 
sorting TGN residents from exocytic cargo. Moreover, Drs2p can be found in exocytic 
vesicles that accumulate in the sec6 mutant, providing a method independent of 
disrupting actin or blocking endocytosis to show targeting of some Drs2p to the plasma 
membrane (Alder-Baerens et al., 2006).  Thus, it is much more likely that disrupting 
endocytosis simply traps Drs2p on the plasma membrane as it undergoes its normal 
trafficking itinerary.  
After endocytosis, Drs2p must also be efficiently removed from the endocytic 
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pathway and transported from the early endosome to the TGN, because we fail to see 
significant accumulation of Drs2p or its Cdc50p subunit in the late endosome of class E 
vps mutants. This is similar to the recycling pathway described for the SNARE protein 
Snc1p and chitin synthase (Chs3p).  In contrast, class E vps mutants accumulate most of 
Vps10p, Mrl1p, Kex2p and Ste13p in the PVC (Cereghino et al., 1995; Brickner and 
Fuller, 1997; Bryant and Stevens, 1997; Andrew Nesbit et al., 2004). Moreover, we never 
detect GFP-Drs2p in the vacuole, which is a common destination for many proteins that 
use Ub for an endocytosis signal because this modification also directs proteins into the 
multivesicular body pathway at the late endosome for delivery to the vacuole lumen 
(Katzmann et al., 2002; Hicke and Dunn, 2003). If Drs2p is ubiquitinated, it must either 
avoid the late endosome to escape vacuolar delivery, or the Ub must be removed to allow 
retrieval of Drs2p to the TGN/early endosomal system. A previous report suggested that 
Drs2p is a late endosomal protein based on a relatively minor localization of Drs2p-GFP 
to the prevacuolar compartment of a class E vps mutant (Saito et al., 2004).  We 
disagree with this interpretation because at the rate of recycling suggested by the cisternal 
maturation model, the majority of Drs2p would relocate to the PVC in class E vps 
mutants if even a small percentage of molecules transited the PVC in each round of 
recycling (as observed for Ste13p and Kex2p). In contrast, a majority of Cdc50-GFP 
(C-terminally tagged) was reported to localize to the PVC (Misu et al., 2003) while we 
found that GFP-Cdc50p (N-terminally tagged) was primarily excluded from the PVC. We 
suggest that the GFP-Cdc50p fusion protein more faithfully represents the localization of 
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the endogenous Drs2p-Cdc50p complex as these data are more consistent with the 
localization data for Drs2p. In summary, it is likely that Drs2p rapidly cycles between the 
TGN and early endosome as suggested for several other TGN proteins, and slowly cycles 
in the TGN Æ plasma membrane Æ early endosome Æ TGN loop.   
Dnf1p is localized to both the plasma membrane and cytoplasmic punctate 
structures typically found near the plasma membrane. The steady-state localization 
pattern of Dnf1p and functional studies suggest that this protein cycles in a plasma 
membrane Æ endosome Æ TGN Æ plasma membrane pathway (Hua et al., 2002). This 
hypothesis was confirmed by studies of the Tanaka group (Saito et al., 2004) and those 
reported here, which extend these studies to demonstrate that endocytosis of Dnf1p is 
dependent on the NPFXD motif and Sla1p. Interestingly, the majority of Dnf1p was 
reported to fractionate in membranes with the same density as the plasma membrane 
(Pomorski et al., 2003; Alder-Baerens et al., 2006), which we have confirmed (our 
unpublished data), but most Dnf1p appears to be inside the cell by immunofluorescence 
localization and is separable from the plasma membrane by differential centrifugation 
techniques. We suggest that these data could be explained by efficient incorporation of 
Dnf1p into exocytic vesicles at the TGN (and/or endosome) and efficient endocytosis at 
the plasma membrane, thus giving a primary steady-state localization to vesicles 
trafficking to and from the plasma membrane. 
 
 82
Synthetic Lethality between drs2 and pan1 
Endocytosis plays an important role in remodeling the plasma membrane, 
internalizing extracellular nutrients, down-regulating signal transduction pathways by 
internalizing receptors, and retrieving proteins required for Golgi/endosome function that 
have escaped to the plasma membrane. The synthetic lethality between pan1-20 and 
drs2-npw1,2 provides the best example we are aware of for the essential role of 
endocytosis in retrieving Golgi proteins. The synthetic lethality between drs2∆ and 
pan1-20 was initially surprising because Drs2p is required for Golgi/early endosome 
function while Pan1p acts at the internalization step of endocytosis. However, the 
relationship between Drs2p and Pan1p is now clearer.  The Ub-dependent endocytosis 
defect of pan1-20 likely depletes the TGN/endosomal system of several proteins required 
for the essential function of these organelles in protein transport. In spite of this deficit, 
Golgi/early endosome function can be maintained as long as Drs2p is present in these 
organelles. In pan1-20, Drs2p localization to the TGN/early endosome requires its 
endocytosis by the NPFXD/Sla1p pathway, thus explaining the inviability of pan1-20 
drs2-npw1,2 (shown here) and pan1 sla1∆ (Tang et al., 1996).  
We have also considered the possibility that the pan1-20 drs2-npw1,2 synthetic 
lethality could be explained by a requirement for Drs2p in the internalization step of 
endocytosis.  However, Dnf1p and Dnf2p appear to provide a much more important 
contribution to endocytosis than Drs2p (Hua et al., 2002; Pomorski et al., 2003).  In 
addition, Dnf1p should be present in the plasma membrane of pan1-20 cells and capable 
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of engaging Sla1p through its NPFXD motif, thus satisfying a potential requirement to 
couple a phospholipid translocase to the endocytic machinery.  Surprisingly, Drs2p does 
not appear to be active on the plasma membrane because end4 cells accumulate Drs2p on 
the plasma membrane, but there does not appear to be a loss of phosphatidylserine 
translocation across the plasma membrane when DRS2 is deleted in end4 cells (Marx et 
al., 1999). Therefore, it is much more likely that TGN/early endosome residence of Drs2p 
is required to sustain viability of pan1-20 cells. Moreover, endocytosis of Dnf1p is 
required in order for this protein to compensate for loss of Drs2p, further arguing for 
critical Golgi functions for these proteins. Class I myosins (Myo3p and Myo5p) are 
required for endocytosis in yeast and CDC50 was recovered in a screen for multicopy 
suppressors of a myo3∆ myo5-360 double mutant growth defect (Misu et al., 2003).   
This suppression could also be explained by an increased Drs2p/Cdc50p concentration in 
the Golgi/early endosome that overcomes the loss caused by the endocytosis defect.      
It is also possible that Pan1p has some unrecognized function in the TGN/early 
endosome system because end3∆, end4∆ and vrp1∆ mutants have a defect in both the 
Ub- and NPFXD-dependent endocytic pathways, accumulate Drs2p on the plasma 
membrane, and yet these mutants are viable while pan1∆ is not. In addition, drs2∆ 
end4-1 and drs2∆ sla1∆ double mutants are viable but the drs2∆ pan1-20 double mutant 
is dead (Chen et al., 1999); this study). One potential explanation for this discrepancy is 
that Pan1p contributes to the clathrin-dependent localization of TGN proteins 
independently of End4p, End3p and Sla1p, perhaps though its interaction with the 
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clathrin assembly protein AP180.  In this case, loss of Pan1p function would accelerate 
transport of TGN proteins to the plasma membrane while trapping them there behind the 
endocytosis block.  Moreover, it seems that the redistribution of GFP-Drs2p from the 
TGN to the plasma membrane occurs faster and more completely in pan1-20 after shift to 
the nonpermissive temperature relative to latrunculin A-treated cells. This potential 
influence of Pan1p on Golgi localization seems to be specific to Drs2p because Kex2p is 
not mislocalized to the plasma membrane of pan1-ts cells. However, further work is 
required to determine whether or not these differences are significant and whether Pan1p 
has any functions beyond the internalization step of endocytosis.    
 
Interactions between Cargo and the Endocytic Machinery 
The nature of the pan1-20 mutation is also of interest because it causes 
cargo-selective defects in endocytosis at the permissive growth temperature, and the 
mechanism for recognition of Ub-dependent endocytic cargo is incompletely understood.  
Pan1p, End3p, End4p and Sla1p are all recruited to the same endocytic sites and are 
considered a coat complex for clathrin/actin-based endocytosis. The Ub-dependent signal 
typically requires phosphorylation prior to ubiquitination by the Rsp5p ubiquitin ligase 
(Rotin et al., 2000; Hicke and Dunn, 2003), then recognition of the ubiquitinated cargo 
by epsins (Ent1p, Ent2p) and Ede1p, another Eps15-related protein, for inclusion into 
forming vesicles (Shih et al., 2002).  Any of these steps could be defective in the 
pan1-20 strain at the permissive temperature and so it will be informative to test whether 
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Drs2-npw1,2p accumulates on the pan1-20 plasma membrane in a phosphorylated and/or 
ubiquitinated form.  Interestingly, the pan1-20 mutation is a frameshift very near the 
carboxyl-terminus within the proline-rich domain of Pan1p (Beverly Wendland, personal 
communication), suggesting this mutation abrogates interaction with a Src homology 
(SH)3-containing protein. One possibility is that this region could potentially interact 
with the SH3 domain of Rvs167p (amphiphysin/endophilin). A point mutation in the SH3 
domain of Rvs167p causes a synthetic lethal interaction with sla1∆ (Friesen et al., 2006), 
as does the pan1-20 allele. Moreover, Sla1p forms a complex with Rvs167 that interacts 
with Rsp5p, comparable to the Cin85-Endophilin interaction with the Cbl ubiquitin ligase 
in mammalian cells (Stamenova et al., 2004).  This network of interactions may play a 
critical role in coupling cargo recognition (by Sla1p, Rsp5p and epsins) to packaging of 
cargo into forming vesicles. 
In summary, the observations reported here are novel in several respects. To our 
knowledge, the inviability of pan1-20 drs2-npw2 represents the first example where 
mutation of an endocytosis signal in a single protein is lethal to a cell. This result 
highlights the importance of endocytosis in retrieving proteins whose primary function is 
in the Golgi/endosomal system. In addition, the selective defect of pan1-20 in 
Ub-dependent endocytosis should facilitate a better understanding of how cargo is 
recognized and packaged into endocytic vesicles through characterization of effectors of 
the Pan1p praline-rich domain.   
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CHAPTER III 
 
DRS2p IS A TGN TO EARLY ENDOSOME ANTEROGRADE CARGO REQUIRED 
FOR AP-1/CLATHRIN-COATED VESICLE FORMATION 
 
Introduction 
Clathrin was the first vesicle coat protein identified and is now known to mediate 
protein traffic from the plasma membrane to endosomes and between the trans-Golgi 
network (TGN) and endosomes. The spherical, cage-like clathrin coats are assembled 
from triskelions, which are three-legged structures containing three clathrin heavy chains 
and three light chains (Brodsky et al., 2001). Clathrin does not bind directly to cargo 
proteins, but instead interacts with pathway-specific adaptors (AP-1, AP-2 etc) that 
associate with the cytosolic sorting signals of cargo proteins (Owen et al., 2004). In 
addition to adaptors, a large variety of accessory factors, such as phosphoinositides, Arf, 
epsins, amphiphysins, AP180 and dynamins, have been identified that also contribute to 
clathrin coated vesicle (CCV) formation (Traub, 2005). These accessory factors facilitate 
a set of sequential steps in vesicle formation: recruitment of adaptors to the appropriate 
membrane, assembly of coat proteins to promote membrane invagination as well as 
selective incorporation of cargo into the forming vesicles, and scission of the membrane 
to release the vesicle.  
The AP-1 and GGA proteins are two major classes of adaptors that function in 
clathrin-mediated transport between the TGN and endosomes (Hinners and Tooze, 2003). 
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AP-1 is composed of two large subunits (β1 and γ), one medium subunit (μ1), and a 
small subunit (σ1). Three other heterotetrameric complexes with homology to AP-1 
function as clathrin adaptors in other protein trafficking pathways (Robinson, 2004). 
AP-2 acts in clathrin-mediated endocytosis and AP-3 is implicated in protein transport 
from endosomes and the TGN to lysosomes. AP-4, absent in yeast, has been involved in 
sorting of cargos destined for lysosomes and the basolateral membrane in different cell 
types. GGA proteins (Golgi-localized, γ-ear-containing, ARF-binding proteins) are 
monomeric adaptors identified by searching sequence databases for homologs of the 
AP-1 γ subunit (Bonifacino, 2004). Mammalian cells express three GGA proteins and 
yeast express two. Like AP-1, GGAs localize to the TGN and endosomal membranes and 
depend on a small GTP binding protein called ADP-ribosylation factor (ARF) for 
membrane association. However, the precise pathways and protein sorting steps mediated 
by AP-1 and GGA are still poorly understood (Hinners and Tooze, 2003). In yeast, 
simultaneous inactivation of both AP-1 and GGA function causes a severe synthetic 
growth defect, suggesting that these adaptors mediate parallel transport pathways 
(Costaguta et al., 2001; Hirst et al., 2001). Current evidence favors a primary role for 
GGAs in the direct TGN to late endosome / prevacuole compartment (PVC) pathway 
(Black and Pelham, 2000; Costaguta et al., 2001; Hirst et al., 2001; Hinners and Tooze, 
2003), while the primary role for AP-1 is proposed to be in the early endosome to TGN 
retrograde pathway (Valdivia et al., 2002; Foote and Nothwehr, 2006). AP-1 is required 
for proper trafficking of several proteins within the TGN/endosome system, including 
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Kex2p, Ste13p, Chs3p, Tgl1p and Cps1p (Valdivia et al., 2002; Ghosh et al., 2003; Foote 
and Nothwehr, 2006; Phelan et al., 2006; Copic et al., 2007). Even though AP-1 is 
recruited to the TGN in yeast and mammals, and is present in clathrin coated buds 
forming on the TGN, no specific anterograde cargo requiring AP-1 has been defined in 
either system.  
A genetic screen to identify accessory factors that function with ARF in vesicle 
biogenesis uncovered a novel requirement for a phospholipid translocase in clathrin 
function at the TGN. This arf1 synthetic lethal screen recovered mutant alleles of DRS2, 
encoding the catalytic α subunit of this P-type ATPase, and CDC50, the noncatalytic 
β-subunit required for chaperoning the αβ complex from the ER to the Golgi (Chen et al., 
1999; Saito et al., 2004; Chen et al., 2006). Drs2p is directly responsible for an 
aminophospholipid translocase activity in the yeast TGN that flips phosphatidylserine 
(PS) and to a lesser extent phosphatidylethanolamine (PE) from the lumenal leaflet to the 
cytosolic leaflet (Natarajan et al., 2004; Alder-Baerens et al., 2006). Mutations in Drs2p 
that disrupt its ATPase or translocase activity phenocopy the effect of clathrin mutations 
on protein trafficking in the TGN and endosomal system. Drs2 and clathrin mutants cause 
mislocalization of TGN proteins, the accumulation of swollen Golgi cisternae, and loss of 
specific class of post-Golgi vesicles carrying exocytic cargo (Chen et al., 1999; Gall et al., 
2002). In addition, drs2Δ cells exhibit a deficiency in CCVs that can be recovered in 
subcellular fractions containing assembled clathrin (Chen et al., 1999). Moreover, Drs2p 
interacts directly with an ARF guanine nucleotide exchange factor Gea2p and Drs2 
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mutations that disrupt this interaction abrogate Drs2p function in vivo (Chantalat et al., 
2004; Liu et al., 2007).  
Drs2p has a steady-state localization to the TGN, although this protein slowly 
traffics to the plasma membrane where it is rapidly endocytosed and efficiently retrieved 
to the TGN from early endosomes (Chen et al., 1999; Saito et al., 2004; Liu et al., 2007). 
As with other TGN proteins, Drs2 likely cycles rapidly to the early endosome and back to 
maintain TGN residence, a pathway linked to AP-1/clathrin function. Here we show that 
Drs2p interacts with AP-1 and loss of AP-1 causes rapid transport to the plasma 
membrane. However, retrieval of Drs2p back to the TGN is unaffected in AP-1 mutants 
and so steady-state localization is not perturbed. These data indicate that Drs2p requires 
AP-1 for anterograde transport to the endosome but not for endosome to TGN retrograde 
transport. We also show that Drs2p is required for AP-1/clathrin function, but does not 
appear to contribute significantly to the GGA/clathrin pathway. AP-1 and clathrin are 
recruited to the Golgi and endosomal membrane in the absence of Drs2p but appear to be 
incapable of budding CCVs. We propose that phospholipid translocation by Drs2p plays 
an essential role in generating the membrane curvature required for budding 
AP-1/clathrin-coated vesicles. 
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Materials and Methods 
 
Media and Strains  
Yeast were grown in standard rich medium (YPD) or synthetic defined (SD) 
minimal media containing the required nutritional supplements (Sherman, 1991). The 
calcoflour white (CW) sensitivity test was done on YPD 2% agar plates containing 100 
μg/ml calcoflour white (F6259; Sigma-Aldrich, St. Louis, MO). Yeast transformations 
were performed using the lithium acetate method. Escherichia coli strains DH5α and 
XL1-Blue were used for plasmid construction and amplification.  
Yeast strains used in this study are summarized in Table 3-1. The yeast knockout 
strain collection was purchased from Resgen, Invitrogen Corporation (Carlsbad, CA). 
Strains carrying multiple disruptions were generated by standard genetic crosses and 
tetrad dissection. The genotype of each clone was determined by PCR as described by the 
Saccharomyces genome deletion project (http://sequence-www.stanford.edu/group/yeast_ 
deletion_project/deletions3.html). The DRS2 disruption plasmid pZH523 (Hua et al., 
2002) was linearized with SacI and HpaI and transformed into different strains to delete 
DRS2. Strains expressing Myc or HA tagged proteins were generated by PCR-based 
targeting into BY4741 or BY4742 strains using pPF6a-13Myc-HisMX6 or 
pPF6a-3HA-HisMX6 as the PCR template (Longtine et al., 1998). Transformants were 
selected on SD plates without histidine and the integrated tags were confirmed by PCR. 
To avoid artifactual accumulation of GFP-Drs2p in the ER (Saito et al., 2004), 
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pGFP-DRS2 was co-transformed into yeast strains with a multicopy vector carrying 
CDC50 (pRS425-CDC50) for experiments shown in Figure 3-4 and 3-5.  
 
Microscopy 
To visualize GFP or DsRed-tagged proteins, cells were grown to mid-log phase, 
harvested and resuspended in imaging buffer (10 mM Tris-HCl pH 7.4, 2% glucose). 
Cells were mounted on glass slides and observed immediately using an Axioplan 
microscope (Carl Zeiss, Thornwood, NY). Fluorescent images were captured with a 
charge-coupled device camera and processed with Metamorph 4.5 software (Universal 
Imaging, Downingtown, PA). Chitin staining was performed with cells incubated in 1 
mg/ml calcofluor white in water for 5 min, and washed 3 times prior to imaging. To study 
the kinetics of GFP-Drs2p transport to the plasma membrane, mid-log phase cells were 
collected and resuspended in SD medium containing 200 μM latrunculin A. Samples of 
cells were imaged at different time points. Brefeldin A (BFA, Sigma, B-7651) was 
dissolved in ethanol and used treat cells at 100 μg/ml in imaging buffer. 
 
Immunological Methods 
For chemical crosslinking experiments, approximately 50 OD600 units of each strain 
were harvested and converted to spheroplasts. After washing the spheroplasts three times 
with crosslinking buffer (1 M Sorbitol, 0.15 M NaCl, 0.1 M KH2PO4 pH 7.2), the cells 
were resuspended in crosslinking buffer supplemented with either 1 or 2 μm 
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dithiobis(succinimidyl)propionate (DSP) (Pierce, Rockford, IL) that was freshly prepared 
as a 20 mg/ml stock in dimethylsulphoxide. Crosslinking reactions were incubated at 
room temperature for 30 minutes. The cells were then pelleted, resuspended in 1 ml 
ice-cold lysis buffer (20 mM Tris-HCl pH 7.5, 1 mM EDTA, 150 mM NaCl, 1% CHAPS, 
1x complete protease inhibitor cocktail lacking EDTA (Roche Diagnostics, Basel, 
Switzerland), 1 mg/ml BSA) and incubated on ice for 15 minutes. The cell lysate was 
cleared by incubation with 30 μl protein G Sepharose (Amersham Biosciences, Sweden) 
at 4°C for 30 minutes and centrifugation at 20,000 x g for 20 minutes. The cleared lysate 
was incubated with 9 μg monoclonal anti-HA (HA-7, Sigma-Aldrich, St. Louis, MO) or 
anti-Myc (9E10, Sigma-Aldrich, St. Louis, MO) antibodies for 1.5 h at 4°C, and 
subsequently with 30 μl protein G Sepharose for 1.5 h at 4°C. The protein G Sepharose 
beads were washed three times with washing buffer I (20 mM Tris-HCl pH 7.5, 1 mM 
EDTA, 350 mM NaCl, 1% Tween-20, 1x complete protease inhibitor cocktail lacking 
EDTA) and twice with washing buffer II (20 mM Tris-HCl pH 7.5, 1 mM EDTA, 150 
mM NaCl, 1x complete protease inhibitor cocktail lacking EDTA). Bound material was 
eluted with SDS/urea sample buffer (40 mM Tris-HCl pH 6.8, 8 M urea, 0.1 mM EDTA, 
1% 2-mercaptoethanol, 5% SDS, 0.25% bromophenol blue) for 20 minutes at 50°C. The 
eluted material was separated by SDS-PAGE and immunoblotting was performed as 
previously described (Chen et al., 1999) using anti-Drs2 (1:2000, (Chen et al., 1999)), 
anti-Arf (1:2000), anti-Apl2 (1:1000, (Yeung et al., 1999)), anti-HA (Sigma-Aldrich, St. 
Louis, MO) and anti-Myc (Sigma-Aldrich, St. Louis, MO) antibodies. 
 93
Table 3-1：Yeast Strains Used in Chapter III. 
Strain  Genotype Source 
BY4741 MATa his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 Invitrogen 
BY4742 MATα his3Δ1 leu2Δ0 ura3Δ0 lys2Δ0 Invitrogen 
BY4741 YDR358W BY4741 gga1Δ::KanMX6 Invitrogen 
BY4742 YHR108W BY4742 gga2Δ::KanMX6 Invitrogen 
BY4741 YKL135C BY4741 apl2Δ::KanMX6 Invitrogen 
BY4741 YPR029C BY4741 apl4Δ::KanMX6 Invitrogen 
BY4741 YLR170C BY4741 aps1Δ::KanMX6 Invitrogen 
BY4741 YPL259C BY4741 apm1Δ::KanMX6 Invitrogen 
BY4741 YHL019C BY4741 apm2Δ::KanMX6 Invitrogen 
BY4741 YJL204C BY4741 rcy1Δ::KanMX6 Invitrogen 
BY4741 YJL036W BY4741 snx4Δ::KanMX6 Invitrogen 
ZHY615D1C MATa his3Δ1 leu2Δ0 ura3Δ0 lys2Δ0 drs2Δ::KanMX6 Hua et al., 2002 
ZHY615M2D BY4742 drs2Δ::KanMX6 Hua et al., 2002 
 BY4742 drs2Δ::LEU2  
KLY691 MATa his3Δ1 leu2Δ0 ura3Δ0 gga1Δ::KanMX6 
gga2Δ::KanMX6 
This Study 
KLY741 gga1Δ::KanMX6 gga2Δ::KanMX6 drs2Δ::LEU2 This Study 
KLY751 MATα his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 apl4Δ::KanMX6 
drs2Δ::LEU2 
This Study 
KLY371 MATa  his3Δ1 leu2Δ0 ura3Δ0 lys2Δ0 apm1Δ::KanMX6 
apm2Δ::KanMX6 
This Study 
BY4742 YJL099W BY4742 chs6Δ::KanMX6 Invitrogen 
KLY022 MATa his3Δ1 leu2Δ0 ura3Δ0 lys2Δ0 drs2Δ::KanMX6 
chs6Δ::KanMX6 
This Study 
KLY492 MATα his3Δ1 leu2Δ0 ura3Δ0 met15Δ0  apl4Δ::KanMX6 
chs6Δ::KanMX6 
This Study 
SEY6210 MATα leu2-3,112 ura3-52 his3-Δ200 trp1-Δ901 lys2-801 
suc2-Δ9 
Robinson et al., 
1988 
KLY281 BY4741 APL4-3XHA::HIS3 This Study 
ZHYDRS2-MYC BY4742 DRS2-13MYC::KanMX6 Hua et al., 2002 
KLY1101 SEY6210 SEC7-DsRed.T4::TRP Chen et al., 2006 
KLY261 KLY1101 drs2Δ::LEU2 This Study 
GGA2-GFP BY4741 GGA2-GFP::HIS3 Invitrogen 
APL1-GFP BY4741 APL1-GFP::HIS3 Invitrogen 
APL2-GFP BY4741 APL2-GFP::HIS3 Invitrogen 
APL6-GFP BY4741 APL6-GFP::HIS3 Invitrogen 
CLC-GFP BY4741 CLC-GFP::HIS3 Invitrogen 
KLY421 BY4741 APL2-GFP::HIS3 drs2Δ::LEU2 This Study 
KLY451 BY4741 GGA2-GFP::HIS3 drs2Δ::LEU2 This Study 
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KLY391 BY4741 CLC-GFP::HIS3 drs2Δ::LEU2 This Study 
KLY791 APL2-GFP X KLY1101 This Study 
KLY795 GGA2-GFP X KLY1101 This Study 
KLY792 CLC-GFP X KLY1101 This Study 
KLY362 KLY451 X KLY261 This Study 
KLY363 KLY421 X KLY261 This Study 
KLY361 KLY391 X KLY261 This Study 
KLY551 MATa his3Δ1 leu2Δ0 ura3Δ0 APL2-GFP::HIS3 
erg6Δ::KanMX6 
This Study 
KLY561 MATα his3Δ1 leu2Δ0 ura3Δ0 lys2Δ0 APL6-GFP::HIS3 
erg6Δ::KanMX6 
This Study 
KLY351 KLY1101 apl2Δ::KanMX6 This Study 
KLY701 MATa his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 apl4Δ::KanMX6 
vps4Δ::KanMX6 
This Study 
KLY711 MATa his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 lys2Δ0 
apl4Δ::KanMX6 vps27Δ::KanMX6 
This Study 
KLY761 BY4741 rcy1Δ::KanMX6 vps27Δ::KanMX6 This Study 
KLY771 BY4742 snx4Δ::KanMX6 vps27Δ::KanMX6 This Study 
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Figure 3-1: Drs2p functions in an AP-1 pathway. 
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Figure 3-1: Drs2p functions in an AP-1 pathway. 
(A) Tetrad analysis of progeny derived from crossing drs2Δ with gga1Δgga2Δ. Circled 
progeny are drs2Δ gga1Δgga2Δ triple mutants. Boxed progeny are drs2Δ gga2Δ double 
mutants.  
(B) Synthetic genetic interaction between drs2 and gga alleles. Growth of the indicated 
strains (From Top to bottom: BY4742, ZHY615M2D, BY4742 YPR029C, KLY691, 
KLY751, KLY741) was assessed by spotting tenfold serial dilutions onto YPD plates and 
growing at 30°C and 23°C  
(C) Cells deficient in Drs2p or AP-1 restore calcofluor white sensitivity to chs6Δ cells. 
Calcofluor white sensitivity was assayed on rich medium supplemented with 100 μg/ml 
calcofluor white.  
(D) Chitin-ring staining is restored to chs6Δ cells by deletion of either AP-1 subunits or 
DRS2. Cell wall chitin was visualized by staining cells with 1 mg/ml calcofluor white. 
(E) Localization of Chs3p to the plasma membrane of chs6Δ is restored by disruption of 
Drs2p or Apl4p. The distribution of proteins between the plasma membrane and the 
internal membranes was determined by centrifugation of cell lysates at 13,000 x g to pellet 
the plasma membrane. Golgi and endosomal membranes remain in the supernatant. 
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Results 
 
Drs2p Is Required for AP-1 Function in the TGN-Early Endosome Pathway 
Previously, we had implicated Drs2p in the formation of clathrin-coated vesicles 
from the TGN-endosomal system (Chen et al., 1999; Gall et al., 2002; Chantalat et al., 
2004). To address whether Drs2p preferentially acts in conjunction with AP-1 or Gga 
clathrin adaptors, we performed a synthetic genetic analysis between mutant alleles 
encoding these proteins. Cell growth is robust when either AP-1 or Gga-mediated 
transport is abolished, but disruption of both pathways causes a dramatic growth defect 
(Costaguta et al., 2001; Hirst et al., 2001). Thus, cells deficient for either adaptor are 
sensitized to perturbations in the function of the other. Therefore, if Drs2p is required for 
AP-1 function, drs2Δ should exhibit a strong synthetic growth defect with 
gga1Δ gga2Δ mutants. Conversely, if AP-1 function is lost in drs2Δ cells, then combining 
AP-1 null alleles with drs2Δ should have no additional consequence. To test this 
possibility, we crossed drs2Δ with gga1Δ gga2Δ and performed a tetrad analysis (Figure 
3-1A). The drs2Δ gga1Δ gga2Δ triple mutant progeny were either inviable or extremely 
slow-growing (Figure 3-1A, circled and 3-1B), and the drs2Δ gga2Δ double mutants 
(Figure 3-1A, boxed) grew slower than drs2Δ or gga2Δ single mutant spores. In contrast, 
when we combined drs2Δ with apl4Δ, a deletion in the γ1 subunit of AP-1, the drs2Δ 
apl4Δ mutant showed a similar growth rate to the drs2Δ single mutant at all temperatures 
tested (Figure 3-1B). For example, drs2Δ grew poorly at 23˚C, but even at this 
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semi-permissive temperature, loss of AP-1 has no additional consequence. These results 
suggest that Drs2p has selective function in AP-1/clathrin mediated traffic but does not 
appear to act in the Gga pathway.  
The best defined role for AP-1 in yeast is in the trafficking of chitin synthase III 
(Chs3p), and so we tested if Drs2p is required in this pathway. Chs3p deposits a ring of 
chitin around emerging buds that remains as a scar after the bud is released. Most Chs3p 
is retained intracellularly by cycling between the TGN and early endosome, but a portion 
is transported to the plasma membrane in a cell-cycle regulated process that requires the 
Chs5p and Chs6p (ChAPs/exomer) coat complex (Santos et al., 1997; Ziman et al., 1998; 
Trautwein et al., 2006; Wang et al., 2006). Thus, chs6∆ cells retain nearly all Chs3p 
intracellularly and have reduced chitin incorporation at the bud site, which makes this 
mutant resistant to toxic effects of calcofluor white (CW), a chitin-binding fluorescent 
compound (Figure 3-1C and (Valdivia et al., 2002; Phelan et al., 2006)). Deletion of any 
AP-1 subunit bypasses the Chs6p requirement, restoring cell surface transport of Chs3p, 
the appearance of chitin rings and CW sensitivity to an AP-1 chs6Δ double mutant 
(Valdivia et al., 2002). Similar to the chs6Δ apl4Δ strain, the chs6Δ drs2Δ double mutant 
failed to grow on the medium containing CW (Figure 3-1C), and formed chitin rings 
morphologically indistinguishable from those in the wild-type and drs2Δ cells (Figure 
3-1D). Subcellular fractionation of membranes by differential centrifugation (9,000g) was 
also used to distinguish Chs3p in the PM and intracellular membrane pools (Figure 3-1E). 
This analysis again indicated that disruption of DRS2 in the chs6Δ background, like 
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disruption of APL4, caused redistribution of Chs3p from internal organelles to the plasma 
membrane fractions, but did not alter the steady-state subcellular distribution of other 
cytosolic (G6PDH) and endosomal (Pep12p) markers. Together, these data indicate that 
deletion of drs2∆ bypasses chs6∆ as effectively as deletion of an AP-1 subunit, consistent 
with a requirement for Drs2p in forming AP-1/clathrin coated vesicles.      
 
Drs2p Associates with AP-1, but Is Not Required to Recruit AP-1 to Membranes 
AP-1 recruitment to Golgi or endosomal membranes of mammalian cells 
requires the small GTP-binding protein ARF. The observation that Drs2p interacts 
directly with an ARF-GEF by its C-terminal tail prompted us to further test if ARF or its 
effector AP-1 can associate with Drs2p. To do so, cells expressing a functional Myc 
tagged version of Drs2p were spheroplasted and treated with dithiobis(succinimidyl) 
-prionate (DSP) before lysis. DSP is a bifunctional, cleavable chemical crosslinking 
reagent that can permeate the cell. Drs2p was immunoprecipitated from the cell lysate, 
the crosslinks were disrupted by reduction, and the immunoprecipitate was probed by 
immunoblotting with affinity-purified polyclonal antibodies to Arf1p and Apl2p, the 
AP-1β subunit. Apl2p, but not Arf1p, co-immunoprecipitated with Drs2p-Myc (Figure 
3-2A). However, Apl2p could not be detected in control immunoprecipitates from cells 
lacking DRS2-Myc. In addition, chemical crosslinking followed by immunoprecipitation 
of HA tagged Apl4p, the AP-1 γ subunit, specifically isolated endogenous Drs2p (Figure 
3-2B). These results indicate that AP-1 can form a complex with Drs2p in yeast cells; 
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however, only a small percentage (0.5%) of Drs2p co-immunoprecipated with AP-1 and 
so this complex is likely to be transient in vivo.   
The requirement for Drs2p in the AP-1/clathrin-dependent Chs3p pathway and 
the association of Drs2p with AP-1 suggested that Drs2p might be required to recruit 
AP-1 and clathrin onto TGN/endosomal membranes. To test this possibility, we compared 
the localization of AP-1β-GFP (Apl2p-GFP) in wild-type and drs2Δ mutant cells. Both 
strains showed a pattern of spots typical of the yeast Golgi and endosomal compartments 
with no indication that membrane association of AP-1 was perturbed in drs2∆ (Figure 
3-2C). We also analyzed the distribution of Apl2p relative to the TGN marker Sec7p. The 
overlap between Apl2p and Sec7p was extensive in both wild-type and drs2Δ cells: in 
wild-type cells, 51% of Apl2-GFP puncta were coincident with Sec7-DsRed puncta and 
in drs2Δ cells, 73% of Apl2-GFP puncta colocalized with Sec7-DsRed puncta. The 
increased association of Apl2-GFP with Sec7-positive membrane is likely caused by 
normal recruitment of AP-1 to the TGN combined with a defect in the release of 
AP-1/clathrin-coated vesicles (Chen et al., 1999; Gall et al., 2000). Localization of GFP 
tagged clathrin light chain (Clc1-GFP) and GGA2 (GGA2-GFP) were also examined in 
these strains and their membrane association appeared to be unaffected (Figure 3-2C). 
Thus, Drs2p is not required for recruitment of AP-1 or clathrin to the TGN membrane, 
even though it appears to be essential for AP-1/clathrin function.  
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Figure 3-2: Drs2p interacts with AP-1 but is not required for AP-1 or clathrin recruitment 
to Golgi membranes.  
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Figure 3-2: Drs2p interacts with AP-1 but is not required for AP-1 or clathrin recruitment 
to Golgi membranes.  
Chemical crosslinking identifies a complex containing Drs2p and AP-1.  
(A) Cells expressing Myc-tagged Drs2p or control cells without the tag were treated with 
crosslinker DSP, lysed, and anti-Myc monoclonal antibodies were used to purify the 
Drs2p-Myc. The crosslinker was cleaved by reduction and bound material was visualized 
by immunoblotting. For the “lysate” lanes, approximately 0.5% of the amount of material 
used for the crosslinking reaction was loaded.  
(B) Cells expressing HA-tagged Apl4p and control cells without the tag were treated as 
described in (A). Anti-HA monoclonal antibodies were used to immunoprecipitate the 
Apl4p-HA.  
(C) Drs2 is not required for Golgi recruitment of AP-1 or clathrin.  
Wild-type and drs2Δ strains expressing the indicated fusion proteins are imaged by 
fluorescence microscopy. 
(D) Membrane association of AP-1 is not affected by deletion of Drs2. 
Wild-type, drs2Δ and pik1-83 cells grown at 30°C were lysed (Lysate, L) and subjected 
to centrifugation at 13,000 x g for 20 min to generate pellet (P1) and supernatant fractions. 
The supernatant fraction was further centrifuged at 100, 000 x g for 1 hour to generate 
pellet (P2) and supernatant (S2) fractions. Different fractions were then immunoblotted 
for Apl2p and Arf1p. 
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Figure 3-3: The punctate localization pattern of AP-1 and AP-3, but not AP-2, is 
dependent on Arf. Cells expressing GFP tagged Apl1p (AP-2 β), Apl2p (AP-1 β) or 
Apl6p (AP-3 β) were grown to log phase, treated with 100 μg/ml BFA and the visualized 
by fluorescence microscopy.  
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Membrane association of AP-1 was also examined in wild-type and 
drs2Δ mutant cells by differential centrifugation. Because it is reported that 
phosphatidylinositol-4-phosphate is required for AP-1 recruitment to the Golgi in 
mammalian cells (Wang et al., 2003), a pik1 mutant, the yeast Golgi resident 
phosphatidylinositol 4-kinase, was also tested. Cell lysates (L) were sequentially 
centrifuged at 10,000 x g and 130,000 x g to collect P1 and P2 pellets, respectively, and 
130,000 x g supernatants (S2), which were probed for AP-1 (Apl2p) and ARF. Apl2p was 
found primarily in the membrane fractions (P1 and P2) while ARF was found primarily in 
the cytosol (S2) fractions (Figure 3-2D). No significant difference in the fractionation 
profile for AP-1 or ARF was detected between wild-type and drs2Δ strains, and we also 
failed to detect any release of Apl2p from the pik1-83 membranes.   
In mammalian cells, AP-1 can be released from membranes by brefeldin A 
(BFA), a drug that binds to an Arf GEF-Arf1-GDP complex and prevents Arf1 activation 
(Peyroche et al., 1999). Wild-type yeast are resistant to BFA, but an erg6Δ mutant, 
defective in one of the final steps of ergosterol biosynthesis, is sensitive (Graham et al., 
1993; Peyroche and Jackson, 2001). To be certain that the punctate localization pattern of 
Apl2-GFP required ARF-dependent membrane localization, we introduced the 
erg6Δ mutation into cells expressing Apl2p-GFP and treated the cells with BFA. In these 
cells, Apl2p-GFP was released from membranes within 1min of treatment with BFA and 
was dispersed throughout the cytosol (Figure 3-3). We also introduced erg6Δ into strains 
expressing GFP tagged Apl1p, the AP-2 α subunit, and GFP tagged Apl6p, the AP-3 β 
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subunit, and treated these cells with BFA. BFA also caused release of GFP-Apl6p (AP-3) 
but not GFP-Apl1p (AP-2) (Figure 3-3). Hence, as with mammalian cells, the dynamic 
association of AP-1 and AP-3 with membranes requires a BFA-sensitive ARF-GEF (i.e. 
Gea1p, Gea2p or Sec7p) while AP-2 does not. These data also indicate that the punctate 
pattern of Apl2p-GFP represents an ARF-dependent membrane-associated pool and 
Drs2p is not required for recruiting AP-1 to the membrane.   
 
Disruption of AP-1 Alters Drs2p Trafficking but not Its Steady-state Localization to 
the TGN 
Our previous work suggested that Drs2 primarily traffics between the TGN and 
early endosome, a pathway associated with AP-1 function (Liu et al., 2007). To test if 
Drs2p localization requires AP-1, we first examined the steady-state localization of 
GFP-Drs2p in wild-type and AP-1-deficient cells. GFP-Drs2p localizes to several discrete 
puncta in wild-type cells, representing the TGN and possibly early endosomes. This 
pattern was not altered in cells lacking AP-1 function (Figure 3-4A, apl2Δ). Furthermore, 
similar levels of overlap between GFP-Drs2p and Sec7p-DsRed were observed for 
wild-type and apl2Δ cells: in wild-type cells 81% of Drs2p-GFP puncta were coincident 
with Sec7-DsRed puncta, while in apl2Δ cells 82% of Drs2p-GFP puncta colocalized 
with Sec7-DsRed puncta. Thus, the steady-state localization of GFP-Drs2p is not affected 
by AP-1 disruption.  
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Figure 3-4: Loss of AP-1 perturbs Drs2p trafficking but not its steady-state localization.  
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Figure 3-4: Loss of AP-1 perturbs Drs2p trafficking but not its steady-state localization.  
(A) Colocalization of Drs2p-GFP and Sec7-DsRed in wild-type and AP-1 deficient 
(apl4Δ) cells. 
(B) Disruption of AP-1 causes rapid accumulation of Drs2p on the plasma membrane 
when endocytosis is blocked. The indicated strains (BY4741, BY4741 YLR170C, 
BY4741 YPR029C, BY4741 YKL135C, BY4741 YPL259C, KLY691, BY4741 
YHL019C, BY4741 YJL204C, KLY371, BY4741 YJL036W) expressing GFP-Drs2p 
were incubated with or without 200 μM latrunculin A (Lat-A) at room temperature for 30 
minutes and then examined by fluorescence microscopy. 
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We then addressed whether deletion of AP-1 has an effect on trafficking of 
GFP-Drs2p. Drs2p slowly cycles in the TGN Æ plasma membrane Æ early endosome Æ 
TGN loop. Acute inactivation of endocytosis by treating cells with latrunculin A (Lat A), 
an inhibitor of actin assembly and endocytosis, causes a rather slow accumulation of 
Drs2p on the plasma membrane over the course of about three hours. If GFP-Drs2p 
rapidly cycles between the TGN and early endosome in an AP-1 pathway, we would 
expect an increased rate of Drs2p transport to either the plasma membrane or late 
endosome in an AP-1 mutant. To test this possibility, we treated wild-type and AP-1 
mutant cells expressing GFP-Drs2p with Lat A and imaged over time. In wild-type cells 
GFP-Drs2p was primarily retained intracellularly in small puncta after 30 minutes of Lat 
A treatment (Figure 3-4B, WT). In stark contrast, deletion of the AP-1 β subunit (APL2), 
γ subunit (APL4), or σ subunit (APS1) caused accumulation of nearly all GFP-Drs2p on 
the plasma membrane after 30 minutes of treatment. This cell surface accumulation of 
GFP-Drs2p was much less pronounced in apm1Δ or apm2Δ cells, which harbor deletions 
of the two alternative AP-1 μ subunits. However, deletion of both APM1 and APM2 leads 
to plasma membrane accumulation comparable to deletion of other AP-1 subunits (Figure 
3-4B), suggesting that the two μ subunits play redundant roles in Drs2p trafficking. To 
determine whether trafficking of Drs2p also requires Gga functions, we treated the gga1Δ 
gga2Δ strain with Lat A and found that these cells slowly accumulated GFP-Drs2p on the 
plasma membrane at a rate similar to wild-type cells. Thus, the fast cell surface 
accumulation of Drs2p after Lat A treatment is specific to AP-1 mutants.  
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AP-1 has been proposed to play a role in retrograde transport from early 
endosome back to the TGN. To determine if the Lat A-induced fast accumulation of 
Drs2p on the plasma membrane in AP-1-deficienct cells was an indirect consequence of 
perturbing early endosome to TGN recycling, we examined the trafficking of GFP-Drs2p 
in two other mutants implicated in early endosome to TGN retrieval (Figure 3-3B, rcy1Δ 
and snx4Δ). However, inactivation of Rcy1p, an F-box protein, only slightly increased the 
rate of GFP-Drs2p accumulation on the cell surface after Lat A treatment, while deletion 
of Snx4p, a sorting nexin had no effect on the rate of GFP-Drs2p plasma membrane 
accumulation. These data suggest a direct requirement for AP-1 in removing Drs2p from 
the exocytic pathway for delivery to the early endosome.  
As a cargo of the AP-1 mediated early endosome to TGN retrograde pathway, 
Chs3p normally avoids transport to the late endosome / prevacuole compartment (PVC) 
but transits this compartment frequently in AP-1 mutants. This perturbation is revealed in 
the class E vps AP-1 double mutants (apl4Δvps4Δ and apl4Δvps27Δ) which trap Chs3p in 
enlarged endosomal compartments adjacent to the vacuole. To test if AP-1 disruption 
perturbs retrograde transport of Drs2p in a manner similar to Chs3p, localization of 
GFP-Drs2p and Chs3p-GFP were monitored in apl4Δ vps4Δ  and apl4Δ vps27Δ  cells. As 
previously observed, Chs3-GFP collapses into a few aberrant structures next to the 
vacuole in both apl4Δ vps4Δ  (Figure 3-5) and apl4Δ vps27Δ   (unpublished results). In 
contrast, GFP-Drs2p does not accumulate in the PVC of these double mutants and shows 
a localization pattern indistinguishable from that in the wild-type cells. Moreover, 
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GFP-Drs2p also appears to localize normally in rcy1Δ vps27Δ and snx4Δ vps27Δ strains 
(Figure 3-5). Thus, GFP-Drs2p does not appear to require AP-1, Rcy1 or Snx4 for its 
exclusion from the late endosome. In summary, these data indicate that AP-1 is required 
for anterograde transport of Drs2p from the TGN back to the early endosome, does not 
require AP-1 for the retrograde trip back to the TGN.     
Snc1p is a v-SNARE that actively cycles along the TGNÆ plasma membrane Æ 
early endosome Æ TGN loop. Drs2p, Rcy1p, and Snx4p are all required for efficient 
Snc1p recycling. In wild-type cells, GFP-Snc1p primarily localizes to the plasma 
membrane concentrating in the regions of polarized growth, with a few intracellular punta 
corresponding to endosomal/TGN compartments. Deletion of DRS2 or RCY1 causes 
accumulation of GFP-Snc1p on internal structures, whereas GFP-Snc1p is missorted to 
the vacuole in snx4Δ cells. To test if AP-1 has any function in the Snc1p recycling 
pathway, we expressed GFP-Snc1p in apl4Δ and apl4Δvps27Δ cells (Figure 3-6 A). 
GFP-Snc1p localized normally in both mutants. We next tested whether loss of AP-1 
function would affect the kinetics of GFP-Snc1p trafficking to the plasma membrane. 
Since most GFP-Snc1p is already present on the cell surface in wild-type and apl4Δ cells, 
we instead treated drs2Δ and drs2Δ apl4Δ strains with Lat A (Figure 3-6 B). Both strains 
have little GFP-Snc1p present on the PM before Lat A treatment and they exhibit similar 
kinetics of Snc1p-GFP accumulation on the PM after treatment. Collectively, these results 
demonstrate that Snc1p trafficking does not seem to require AP-1 function. 
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Figure 3-5: GFP-Drs2p is not trapped in the late endosome/PVC in AP-1, rcy1 or snx4 
mutants.  
(A) In apl4Δ vps27Δ cells, Chs3p-GFP accumulates in the class E compartments, while 
GFP-Drs2p appears to localize normally to the TGN. 
apl4 Δvps27Δ strains expressing GFP-Drs2p or Chs3p-GFP are imaged by fluorescence 
microscopy. Arrowheads indicate the class E compartments. 
(B) Localization of GFP-Drs2p in rcy1Δ vps27Δ and snx4Δ vps27Δ cells. 
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Figure 3-6: Loss of AP-1 does not perturb Snc1p trafficking and its steady-state 
localization. 
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Figure 3-6: Loss of AP-1 does not perturb Snc1p trafficking and its steady-state 
localization. 
(A) Localization of Snc1p-GFP in wild-type cells and various mutants that disrupt protein 
trafficking in the TGN-endosomal system. 
(B) Deletion of AP-1 from drs2Δ cells does not alter the trafficking kinetics of 
Snc1p-GFP. drs2Δ and drs2Δ apl4Δ cells expressing GFP-Drs2p were incubated with or 
without 200 μM latrunculin A (Lat-A) at room temperature for 30 min or 2 h and then 
examined by fluorescence microscopy. 
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Discussion 
A major goal of this study is to address the relationship between the clathrin 
adaptor AP-1 and Drs2p, a potential phospholipid translocase, in clathrin mediated 
protein trafficking. Our results demonstrate that Drs2p and AP-1 function together to 
mediate protein transport between the TGN and early endosome, and that these proteins 
interact directly or indirectly. Deletion of DRS2 does not seem to affect recruitment of 
AP-1 to the TGN membrane, suggesting that Drs2p is required at late stages in 
AP/clathrin-coated vesicle formation. In addition, disruption of AP-1 causes missorting of 
Drs2p to the plasma membrane as judged by fast plasma membrane accumulation of 
Drs2p after acute inactivation of endocytosis. These results define Drs2p as an 
anterograde cargo for AP-1.  
 
Potential Roles Drs2p Might Play in Budding Clathrin-Coated Vesicles 
Previous studies have demonstrated that Drs2p, a phospholipid translocase, plays 
a role in the CCV formation from the TGN and endosomal membranes (See Introduction). 
Several lines of evidence indicated that the translocase activity of Drs2p is required for its 
function in vesicle biogenesis. Acute inactivation of drs2-ts by temperature shift 
abrogates the translocation of NBD-PS, a fluorescent phosphatidylserine derivative, 
across the purified TGN membrane as well as the formation of a clathrin-dependent class 
of exocytic vesicles (Gall et al., 2002; Natarajan et al., 2004). Moreover, an ATPase-dead 
allele of Drs2 (drs2-D560N) fails to complement drs2Δ defects in dense exocytic vesicle 
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formation and the recycling of the exocytic v-SNARE Snc1p (Chen et al., 1999; 
Chantalat et al., 2004; Liu et al., 2007).  
Two models have been proposed to explain how the phospholipid translocase 
activity of Drs2p contributes to vesicle biogenesis (Chen et al., 1999). One possibility is 
that Drs2p may affect the recruitment of peripherally associated proteins by increasing 
the concentration of some specific phospholipid on the cytosolic leaflet. However, our 
results rule out this possibility by showing that membrane association of coat components 
required for vesicle formation, such as AP-1, GGA2, AP-3 and clathrin, is independent of 
Drs2p. In addition, we had previously shown that recruitment of the Arf-GEF Gea2p to 
the TGN does not require Drs2p (Chantalat et al., 2004). In fact, we observed a modest 
clustering of Clc-GFP in drs2Δ haploid cells. Therefore, in contrast to current models for 
CCV budding, our data argue that membrane recruitment of Arf-GEF, Arf, AP-1 and 
clathrin is insufficient to bud AP-1/clathrin-coated vesicles in the absence of Drs2p. 
An alternative possibility is that the transbilayer movement of lipids mediated by 
Drs2p helps to bend the membrane to facilitate vesicle budding. According to the 
bilayer-couple hypothesis of Sheetz and Singer, the two leaflets of membrane are 
physically coupled together and a relative increase in surface area of one leaflet would 
spontaneously induce membrane curvature (Sheetz and Singer, 1974; Sheetz et al., 1976). 
Both in erythrocytes and pure phospholipid model systems, bilayer asymmetry induced 
by insertion of additional lipids in one of the membrane leaflets leads to dramatic shape 
changes (Seigneuret and Devaux, 1984; Daleke and Huestis, 1985; Daleke and Huestis, 
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1989; Farge and Devaux, 1992). When the surface area of outer leaflet is increased 
relative to the inner leaflet, the closed lipid bilayer system (e.g. liposomes, erythrocytes) 
will become crenated, tubulated or vesiculated. When the surface area of inner leaflet is 
increased relative to the outer leaflet, the membrane becomes concave. A large group of 
proteins, which have the potential to induce the transbilayer area asymmetry, have been 
implicated in protein trafficking, including proteins with amphipathic helixes that could 
physically penetrate into one face of the bilayer (e.g. endophilin, amphiphysin, epsin 
(Itoh and De Camilli, 2006; Ren et al., 2006)), lipid transfer proteins, lipid metabolic 
enzymes (e.g. sphingomyelinase (Zha et al., 1998), lysophosphatidic acid transferases 
(Schmidt et al., 1999; Weigert et al., 1999)), as well as lipid translocases (Graham, 2004). 
By translocating phospholipids from the lumenal leaflet to the cytosolic leaflet, 
phospholipid translocases could increase the surface area of the cytosolic leaflet and bend 
the membrane towards the cytosol. Indeed, ATP-dependent inward translocation of 
exogenous PS and PE by phospholipid translocase on the plasma membrane of human 
erythroleukemia cells enhances bulk endocytosis (Farge et al., 1999). Consistent with a 
putative role of Drs2p in regulating membrane curvature, Golgi membranes in the drs2Δ 
mutants are notable for their lack of fenestration or tubular regions (Chen et al., 1999), 
whereas the Golgi in arf1Δ mutants is highly fenestrated or tubular in appearance 
(Gaynor et al., 1998).  
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Drs2p Is an Anterograde Cargo of AP-1 
In wild-type cells, Drs2p primarily cycles between the TGN and early endosomes, 
and only visits the plasma membrane occasionally (Liu et al., 2007). Strikingly, in the 
AP-1 mutants, Drs2p rapidly traffics to and from the plasma membrane, but still maintian 
its steady-state TGN residence. How AP-1 affects the trafficking itinerary of Drs2p could 
be explained by two possibilities. First, AP-1 may mediate the retrieval of Drs2p from 
early endosome back to the TGN. In this case, loss of AP-1 would cause accumulation of 
Drs2p at the early endosome, from which Drs2p could potentially recycle to the plasma 
membrane. The second possibility is that AP-1 is required for the anterograde transport of 
Drs2p from the TGN to early endosomes. When AP-1 is disrupted, Drs2p is incorporated 
into exocytic vesicles targeted to the plasma membrane more frequently than in a 
wild-type cell. The second possibility is favored by several experimental results. The 
extensive colocalization between Drs2p and the TGN marker Sec7p remains in the AP-1 
mutant, indicating that endocytosis and early endosome to TGN transport of Drs2p is 
unaffected by loss of AP-1. If Drs2p accumulated in the early endosome in AP-1 deficient 
cells, we would expect it to traffic more frequently to the late endosome/PVC, like Chs3p. 
However, Drs2p is not trapped in the class E compartments of apl2Δvps27Δ or 
apl4Δvps4Δ cells, suggesting that Drs2p does not transit through the late endosome/PVC, 
even in the absence of AP-1. Thus, inactivation of AP-1 does not seem to cause 
accumulation of Drs2p in the early endosome. The Snx4-Snx41-Snx42 complex and the 
F-box protein Rcy1p have both been implicated in the transport pathway from early 
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endosome back to the TGN (Wiederkehr et al., 2000; Hettema et al., 2003). In rcy1Δ cells 
the Drs2p/Cdc50p complex colocalizes extensively with Snc1p-positive structures, which 
are probably derived from early endosomes (Furuta et al., 2007). These results, in 
combination with the physical interaction between Drs2p and Rcy1p, indicate that Rcy1p 
is involved in early endosome to TGN retrieval of Drs2p. However, disruption of Rcy1 
only slightly increases the rate of Drs2p transport to the plasma membrane, while 
disruption of Snx4-Snx41-Snx42 has no apparent impact on Drs2p trafficking. Thus, the 
substantially enhanced plasma membrane trafficking of Drs2p in AP-1 deficient cells is 
more likely due to missorting of Drs2p at the TGN into secretory vesicles than a 
secondary effect of Drs2p accumulation at the early endosome.  
A(F->A)ALP is a Ste13p based reporter protein which is thought to primarily 
traffic between the TGN and early endosome, but accumulates relatively slowly in the 
late endosome of class E vps mutants. AP-1 directly binds to the cytosolic tail of 
A(F->A)ALP and reduces its rate of trafficking to the late endosome (Foote and 
Nothwehr, 2006). Chs3p also accumulates rapidly in the late endosome of AP-1 mutants. 
These results suggest that AP-1 functions to retrieve proteins from the early endosome 
back to the TGN. However in this study, we demonstrate that AP-1 primarily mediates 
the anterograde transport of Drs2p from the TGN to the early endosome. Moreover, loss 
of AP-1 function restores the transport of Chs3p to the cell surface under conditions in 
which the normal export route of Chs3p is blocked (Valdivia et al., 2002). Thus, AP-1 
seems to function in both anterograde and retrograde pathways between the TGN and 
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early endosome. Remarkably, Drs2p appears to only use AP-1 for anterograde transport, 
while Chs3p may use AP-1 for both pathways. In fact, similar phenomena could also be 
observed for other clathrin adaptors such as GGA proteins. The GGA proteins are 
implicated in the direct TGN to late endosome transport of Pep12p (Black and Pelham, 
2000) and Vps10p (Costaguta et al., 2001), and a recent study demonstrated that GGA 
mutations have an impact on trafficking of Chs3p and A(F->A)ALP similar to AP-1 
mutations. These results imply that GGA proteins may, like AP-1, play a role in 
TGN/early endosome pathways (Copic et al., 2007). How the adaptors achieve this 
ability to perform a cargo-specific function is still not clear, but likely to involve the 
recognition of pathway-specific sorting signals.  
 
Transport Pathways that Involve Drs2p 
As we have discussed above, AP-1 and GGA proteins have redundant and 
non-redundant functions in clathrin-mediated transport between the TGN and endosomes. 
Simultaneous inactivation of AP-1 and GGA proteins causes a severe synthetic growth 
defect, while perturbation on either AP-1 or GGA mediated transport has little impact on 
cell growth (Costaguta et al., 2001; Hirst et al., 2001). Similar genetic interactions are 
found between Drs2 and the GGA proteins, but not between Drs2 and AP-1, suggesting 
that Drs2p is required for essential function of AP-1 but not that of the GGA proteins. 
However, Drs2p has a more substantial impact on protein trafficking than AP-1, since 
drs2 mutants display more severe defects than AP-1 in both protein transport and cell 
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growth. Drs2p also play roles in AP-1 independent transport pathways, such as the AP-3 
mediated alkaline phosphatase pathway to the vacuole and the Snc1p recycling pathway 
(Hua et al., 2002; Liu et al., 2007).   
Interestingly, unlike other proteins that frequently transit the TGN (e.g. Kex2p, 
Chs3p, Vps10p, Snc1p), Drs2p is never trapped in the late endosome derived class E 
compartment in various mutants we tested (vps4Δ, vps27Δ, apl2Δvps27Δ, rcy1Δvps27Δ, 
snx4Δvps27Δ). It seems that the cells go to great lengths to prevent Drs2p from getting 
into the late endosome. The normal function of the late endosome/multivesicular body 
requires production of negative membrane curvature on its surface to facilitate the inward 
budding of vesicles. Considering that the proposed role for Drs2p is to induce positive 
membrane curvature, it is tempting to speculate that the presence of Drs2p on the late 
endosome/multivesicular body would be detrimental to late endosome function, and thus 
Drs2p is excluded from this compartment.  
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CHAPTER IV 
 
SUMMARY 
 
Drs2p, a P-type ATPase, is a phospholipid translocase at the yeast TGN that flips 
phosphatidylserine (PS) and to a lesser extent phosphatidylethanolamine (PE) from the 
luminal leaflet to the cytosolic leaflet (Natarajan et al., 2004; Alder-Baerens et al., 2006). 
Interestingly, mutations in Drs2p that disrupt its ATPase or translocase activity 
phenocopy the effect of clathrin mutations on protein trafficking in the TGN and early 
endosomal system (Chen et al., 1999; Gall et al., 2002). In addition, drs2Δ cells exhibit a 
deficiency in clathrin-coated vesicles that can be recovered in subcellular fractions 
containing assembled clathrin (Chen et al., 1999). Moreover, Drs2p is engaged in 
extensive genetic and physical interactions with vesicle budding machinery acting in the 
TGN-early endosomal system (Chen et al., 1999; Chantalat et al., 2004; Saito et al., 2004; 
Sakane et al., 2006; Furuta et al., 2007). Although all these evidences suggest that Drs2p 
is implicated in clathrin-mediated protein trafficking, two fundamental questions remain: 
1) What mechanism does Drs2p use to facilitate clathrin coated vesicle biogenesis? 2) 
How is Drs2p function coupled to specific transport pathways? In this study, we 
attempted to answer these two questions by examining the trafficking itinerary, protein 
interactions and biological function of Drs2p. 
Previously, two models have been proposed to describe the role Drs2p might play 
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in vesicle formation. One model proposes that Drs2p may help to recruit peripherally 
associated coat proteins by protein interactions or by concentrating specific phospholipid 
molecules on the cytosolic leaflet of the membrane. To test this model, we studied the 
membrane association of the coat componenets required for vesicle formation such as 
AP-1, AP-3 and clathrin and found that they are recruited to the Golgi and endosomal 
membrane in absence of Drs2p. In addition, we had previously shown that recruitment of 
the Arf-GEF Gea2p to the TGN does not require Drs2p (Chantalat et al., 2004). The 
GGA/clathrin pathway appears functional in the absence of Drs2p, but AP-1/clathrin 
pathways require Drs2p activity. Therefore, in contrast to current models for CCV 
budding, our data argue that membrane recruitment of Arf-GEF, Arf, AP-1 and clathrin is 
insufficient to bud AP-1/clathrin-coated vesicles in the absence of Drs2p.  
In an alternative model, phospholipid translocation by Drs2p may help to bend the 
membrane to facilitate vesicle budding. According to the bilayer-couple hypothesis of 
Sheetz and Singer, the two leaflets of membrane are physically coupled together and a 
relative increase in surface area of one leaflet spontaneously induces membrane curvature 
(Sheetz and Singer, 1974; Sheetz et al., 1976). By translocating phospholipid from the 
lumenal leaflet to the cytosolic leaflet of the TGN or early endosomes, Drs2 would 
increase the surface area of the cytosolic leaflet relatively to the lumenal leaflet, and bend 
the membrane towards the cytosol. We propose that Drs2p imparts curvature to the 
membrane through a bilayer-couple mechanism that is captured by coat proteins to 
produce vesicles. To test this hypothesis, futher studies need to be done with purified and 
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reconstituted Drs2p in liposomes. 
Although bending membrane is a common requirement for formation of all kinds 
of vesicles, Drs2p seems to only function in specific post-Golgi pathways. How Drs2p 
activity is coupled to these pathways remains unknown, but it is essential that Drs2p 
maintains its appropriate localization to the TGN/early endosome system. To do this, 
Drs2p primarily cycles between the TGN and the early endosome, and it occasionally 
traffics to the plasma membrane where it is rapidly endocytosed and efficiently retrieved 
to the TGN from early endosomes. Endocytosis of Drs2p is mediated by multiple signals, 
including two NPFXD motifs near the C terminus and PEST-like sequences near the N 
terminus for ubiquitin-dependent endocytosis. The NPFXD motifs can be specifically 
recognized by Sla1p, part of an endocytic coat/adaptor complex with clathrin, Pan1p, 
End3p, and Sla2p. When both ubiquitin- and NPFXD- dependent endocytic mechanisms 
are abrogated, Drs2p accumulates on the plasma membrane. In pan1-20 
temperature-sensitive mutants, mislocalization of Drs2p to the plasma membrane is lethal 
to the cell, demonstrating a requirement for Drs2p at the TGN and endosomes to sustain 
viability of pan1-20. 
AP-1 and GGA proteins are two classes of clathrin adaptors that play both 
redundant and nonredundant roles in transport between the TGN and endosomes. AP-1 is 
required for the anterograde transport of Drs2p to the early endosome, while GGA 
proteins have little impact on Drs2p trafficking. Interestingly, Drs2p is implicated in 
AP-1/clathrin function but does not appear to contribute significantly to the GGA/clathrin 
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pathway. These observations indicate that Drs2p activity is tightly coupled to 
AP-1/clathrin coated vesicle budding, and that Drs2p becomes a cargo of these vesicles 
during their formation. Drs2p and AP-1 act in close proximity as they can be crosslinked 
in a complex. It remains to be determined whether Drs2p and AP-1 directly interact and if 
Drs2p has a sorting signal recognized by AP-1. Interestingly, Drs2p and clathrin are 
required for biogenesis of a class of dense exocytic vesicles, but Drs2p does not appear to 
be efficiently incorporated into these vesicles.  
Despite these findings, many mysteries still remain. Although Drs2p is directly 
responsible for the translocation of NBD-PS across the TGN membrane, PS deficient 
mutants transport and process proteins normally in the secretory pathway, and still require 
Drs2p for vesicle formation. These results strongly suggest that Drs2p must pump some 
other substrates that may play a more critical role in transport vesicle formation. Drs2p 
appears to weakly translocate PE, and it is possible that the precise lipid translocated is less 
important than the physical displacement of lipid to distort the membrane. Purification and 
reconstitution of Drs2p in liposomes with defined lipid composition will help us to better 
understand the biochemical function of this protein. Moreover, the C-terminal tail of Drs2p 
has been found to be essential for its function and mediates a direct interaction with Gea2p, 
an ARF-GEF, by the Gea2p interacting motif (GIM). Adjacent to the GIM, there is another 
motif conserved among all Drs2p homologues that is homologous to a lipid-binding motif 
in Vps36p. Whether these interactions with proteins or lipids have a regulatory role for 
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Drs2p activity is not clear. More investigation will be needed to address these 
fundamentally important questions.  
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